publication_id,quote,best_match_source,best_match,similarity
1528,"Participants were screened on the General Health Questionnaire 12 and Hospital Anxiety and Depression Scale, and those with low mood were recruited.",fulltext,"Participants: People with multiple sclerosis were screened on the General Health Questionnaire 12 and Hospital Anxiety and Depression Scale, and those with low mood were recruited.",100.0
1528,"Participants were included who scored >2 on the General Health Questionnaire 12, a measure of psychological distress, or >7 on the anxiety and depression subscales of the Hospital Anxiety and Depression Scale, thus confirming they had low mood.",fulltext,"participants were included who scored >2 on the General Health Questionnaire 12,7 a measure of psychological distress, or >7 on the anxiety and depression subscales of the Hospital Anxiety and Depression Scale,8 thus confirming they had low mood.",100.0
1528,"Participants randomly allocated to the adjustment group received six group treatment sessions. The control group received usual care, which did not include psychological interventions.",fulltext,"Participants randomly allocated to the adjustment group received six group treatment sessions. The control group received usual care, which did not include psychological interventions.",100.0
1528,"The groups were delivered by two Band 5 assistant psychologists, who were supervised by a Band 8a clinical psychologist, experienced in working with people with multiple sclerosis.",fulltext,"The groups were delivered by two Band 5 assistant psychologists, who were supervised by a Band 8a clinical psychologist, experienced in working with people with multiple sclerosis.",100.0
1528,"The total running costs for the programme were £17,824. This was based on 54 three-hour sessions (including room hire and refreshments) and the salary of two NHS Band 5 assistant psychologists and one Band 8a clinical psychologist.",fulltext,"The total running costs for the programme were £17,824. This was based on 54 three-hour sessions (including room hire and refreshments) and the salary of two NHS Band 5 assistant psychologists and one Band 8a clinical psychologist.",100.0
1528,Participants randomly allocated to the adjustment group received six group treatment sessions.,fulltext,Participants randomly allocated to the adjustment group received six group treatment sessions.,100.0
1528,The groups involved teaching people to recognise symptoms of distress and introduced them to strategies to improve their mood.,fulltext,The groups involved teaching people to recognise symptoms of distress and introduced them to strategies to improve their mood.,100.0
1528,"Four and eight months after random allocation, participants were sent a booklet of outcome questionnaires to complete and return by post.",fulltext,"Four and eight months after random allocation, participants were sent a booklet of outcome questionnaires to complete and return by post.",100.0
1528,"Outcomes were assessed four and eight months after randomization, blind to group allocation. The costs were assessed from a service use questionnaire and information provided on medication. Quality of life was assessed using the EQ-5D.",fulltext,"Outcomes were assessed four and eight months after randomization, blind to group allocation. The costs were assessed from a service use questionnaire and information provided on medication. Quality of life was assessed using the EQ-5D.",100.0
1528,"Owing to the level of missing EQ-5D data at follow-up, a ‘last value carried forward’ imputation approach was adopted.",fulltext,"Owing to the level of missing EQ-5D data at follow-up, a ‘last value carried forward’ imputation approach was adopted.",100.0
1529,"The inclusion criteria were being definitely diagnosed with MS and having records in the Society and the exclusion criteria having history of other psychiatric disorders including major depressive disorder (according to the medical records and the physician's examinations) or bipolar disorder (except for cognitive disorders by which MS is characterized), substance dependency, any neurological disorders, history of taking corticosteroids or the disease recurrence within the previous six months.",fulltext,"The inclusion criteria were being definitely diagnosed with MS and having records in the Society and the exclusion criteria having history of other psychiatric disorders including major depressive disorder (according to the medical records and the physician's examinations) or bipolar disorder (except for cognitive disorders by which MS is characterized), substance dependency, any neurological disorders, history of taking corticosteroids or the disease recurrence within the previous six months.",100.0
1529,"To follow randomized assignment, we decided to run the sampling within two consecutive months until we enrolled an adequate number of participants. Accordingly, 70 numbers, equal to the number of people required in each group, were developed and the numbers 1–70 were randomly assigned to two groups: experimental and control. After eligible patients referred to the Association, a number was randomly assigned to each patient according to his/her referring time and the patients were assigned to the two groups.",fulltext,"To follow randomized assignment, we decided to run the sampling within two consecutive months until we enrolled an adequate number of participants. Accordingly, 70 numbers, equal to the number of people required in each group, were developed and the numbers 1–70 were randomly assigned to two groups: experimental and control. After eligible patients referred to the Association, a number was randomly assigned to each patient according to his/her referring time and the patients were assigned to the two groups.",100.0
1529,"This training program was conducted within eight 1- to 1.5-h sessions, two sessions a week through lecturing, group discussions, and question and answering, such that the scientific materials were offered within the first half-time of each session and, after a rest, the group discussions and questioning and answering were run about the drills of the subject of interest in the second half-time.",fulltext,"This training program was conducted within eight 1- to 1.5-h sessions, two sessions a week through lecturing, group discussions, and question and answering, such that the scientific materials were offered within the first half-time of each session and, after a rest, the group discussions and questioning and answering were run about the drills of the subject of interest in the second half-time.",100.0
1529,"To measure fatigue, the Piper Standard Scale was used. This scale consists of 27 items that measures fatigue in terms of four domains: behavioral, affective, tactile, and cognitive.",fulltext,"To measure fatigue, the Piper Standard Scale was used. This scale consists of 27 items that measures fatigue in terms of four domains: behavioral, affective, tactile, and cognitive.",100.0
1529,"Because the patients were not hospitalized and regularly referred to the Association, to follow randomized assignment, we decided to run the sampling within two consecutive months until we enrolled an adequate number of participants.",fulltext,"Because the patients were not hospitalized and regularly referred to the Association, to follow randomized assignment, we decided to run the sampling within two consecutive months until we enrolled an adequate number of participants.",100.0
1529,"To investigate depression, anxiety, and stress, DASS-21, developed by Lovibond and Lovibond in 1995, was used and its validity and reliability were confirmed [17]. To measure fatigue, the Piper Standard Scale was used.",fulltext,"To investigate depression, anxiety, and stress, DASS-21, developed by Lovibond and Lovibond in 1995, was used and its validity and reliability were confirmed [17]. To measure fatigue, the Piper Standard Scale was used.",100.0
1567,Persons with MS (N = 183) with cognitive concerns were randomly assigned to either the 8-week MAPSS-MS intervention or usual care plus freely available computer games.,fulltext,Persons with MS (N = 183) with cognitive concerns were randomly assigned to either the 8-week MAPSS-MS intervention or usual care plus freely available computer games.,100.0
1567,"The Perceived Deficits Questionnaire19 was administered by phone, and those scoring at least 10 (indicating some problems in at least 5 areas) were eligible to participate.",fulltext,"The Perceived Deficits Questionnaire19 was administered by phone, and those scoring at least 10 (indicating some problems in at least 5 areas) were eligible to participate.",100.0
1567,"Participants were recruited via physician referral, targeted mailings to persons with MS on the mailing list of the National MS Society, contact with support groups, and notices in MS newsletters and web sites.",fulltext,"Participants were recruited via physician referral, targeted mailings to persons with MS on the mailing list of the National MS Society, contact with support groups, and notices in MS newsletters and web sites.",100.0
1567,The 347 persons who were initially screened as “eligible” were later contacted by phone to invite their participation during specific dates.,fulltext,The 347 persons who were initially screened as “eligible” were later contacted by phone to invite their participation during specific dates.,100.0
1567,"Following approval by the Institutional Review Board for the University of Texas at Austin, participants were recruited from three large metropolitan communities in Texas: Houston, San Antonio and Dallas.",fulltext,"Following approval by the Institutional Review Board for the University of Texas at Austin, participants were recruited from three large metropolitan communities in Texas: Houston, San Antonio and Dallas.",100.0
1567,The MAPSS-MS intervention aims to help persons with MS acquire the highest level of cognitive functioning and functional independence. The intervention includes group sessions (2 h per week for 8 weeks) focused on building efficacy for use of cognitive strategies and a home-based computer training program (45 min three times per week).,fulltext,The MAPSS-MS intervention aims to help persons with MS acquire the highest level of cognitive functioning and functional independence. The intervention includes group sessions (2 h per week for 8 weeks) focused on building efficacy for use of cognitive strategies and a home-based computer training program (45 min three times per week).,100.0
1567,"Based on the integration of Bandura’s self-efficacy theory20 with the investigators’ prior intervention studies,21,22 the program’s conceptual model proposes accurate knowledge of cognitive problems, lifestyle adjustments (sleep, stress management, physical activity) that support cognitive functioning, and self-efficacy to manage cognitive challenges will support persons with MS in the use of compensatory cognitive strategies and cognitive skills.",fulltext,"Based on the integration of Bandura’s self-efficacy theory20 with the investigators’ prior intervention studies,21,22 the program’s conceptual model proposes accurate knowledge of cognitive problems, lifestyle adjustments (sleep, stress management, physical activity) that support cognitive functioning, and self-efficacy to manage cognitive challenges will support persons with MS in the use of compensatory cognitive strategies and cognitive skills.",100.0
1567,"The first four sessions focused on common cognitive problems experienced with MS (attention and processing speed, memory and language, visuospatial and executive functioning) and development of relevant compensatory strategies. The final four sessions focused on lifestyle behaviors to support cognitive functioning, including managing fatigue and stress and increasing physical activity.",fulltext,"The first four sessions focused on common cognitive problems experienced with MS (attention and processing speed, memory and language, visuospatial and executive functioning) and development of relevant compensatory strategies. The final four sessions focused on lifestyle behaviors to support cognitive functioning, including managing fatigue and stress and increasing physical activity.",100.0
1567,"Although individuals varied their computer training time from week to week, 68% met or exceeded the total time prescribed over the 8-week intervention. About half met or exceeded the goal each week.",fulltext,"Although individuals varied their computer training time from week to week, 68% met or exceeded the total time prescribed over the 8-week intervention. About half met or exceeded the goal each week.",100.0
1567,"Neuropsychological testing and questionnaire data were collected from all subjects at baseline, following completion of the intervention, and 3 and 6 months post-intervention.",fulltext,"Neuropsychological testing and questionnaire data were collected from all subjects at baseline, following completion of the intervention, and 3 and 6 months post-intervention.",100.0
1567,"Persons with MS (N = 183) with cognitive concerns were randomly assigned to either the 8-week MAPSS-MS intervention or usual care plus freely available computer games. Participants completed self-report and performance measures of cognitive functioning, compensatory strategies and depression at baseline, immediately after the MAPSS-MS intervention, and three and six months post-intervention.",fulltext,"Persons with MS (N = 183) with cognitive concerns were randomly assigned to either the 8-week MAPSS-MS intervention or usual care plus freely available computer games. Participants completed self-report and performance measures of cognitive functioning, compensatory strategies and depression at baseline, immediately after the MAPSS-MS intervention, and three and six months post-intervention.",100.0
1567,"Changes in study outcomes were analyzed using intention to treat methodology, ANOVA with repeated measures, and ANCOVA.",fulltext,"Changes in study outcomes were analyzed using intention to treat methodology, ANOVA with repeated measures, and ANCOVA.",100.0
1568,"Inclusion criteria were (1) 18–60  years of age, (2) ⩽2 years since clinical diagnosis with relapsing remitting MS (RRMS) and (3) no relapses or changes in medication status 8 weeks prior to inclusion.",fulltext,"Inclusion criteria were (1) 18–60  years of age, (2) ⩽2 years since clinical diagnosis with relapsing remitting MS (RRMS) and (3) no relapses or changes in medication status 8 weeks prior to inclusion.",100.0
1568,Patients (n = 84) were recruited in collaboration with six Danish regional MS clinics and The Danish MS Society.,fulltext,Patients (n = 84) were recruited in collaboration with six Danish regional MS clinics and The Danish MS Society.,100.0
1568,The exercise intervention included 3892 minutes of aerobic exercise at an average intensity of 76.2% HRmax. The exercise sessions consisted of continuous sessions lasting 30–60 minutes with an intensity of 60%–80% HRmax and interval training sessions lasting 30–60 minutes with an interval duration of 1–10 minutes and intensities varying from 65%–95% HRmax.,fulltext,The exercise intervention included 3892 minutes of aerobic exercise at an average intensity of 76.2% HRmax. The exercise sessions consisted of continuous sessions lasting 30–60 minutes with an intensity of 60%–80% HRmax and interval training sessions lasting 30–60 minutes with an interval duration of 1–10 minutes and intensities varying from 65%–95% HRmax.,100.0
1568,Patients received the exercise intervention in addition to usual care.,fulltext,Patients received the exercise intervention in addition to usual care.,100.0
1568,"The exercise intervention was planned as high-intense aerobic exercise, monitored relative to the patients’ individual maximal heart rate (HRmax), and progressed within and between 4 meso cycles of 12 weeks.",fulltext,"The exercise intervention was planned as high-intense aerobic exercise, monitored relative to the patients’ individual maximal heart rate (HRmax), and progressed within and between 4 meso cycles of 12 weeks.",100.0
1568,"All patients were scanned using the exact same 3-Tesla MRI scanner (MAGNETOM Skyra, Siemens Medical Systems, Erlangen, Germany) at the same location, for all patients, and at all timepoints.",fulltext,"All patients were scanned using the exact same 3-Tesla MRI scanner (MAGNETOM Skyra, Siemens Medical Systems, Erlangen, Germany) at the same location, for all patients, and at all timepoints.",100.0
1568,The annual relapse rate and the global brain atrophy rate were the primary outcomes of this study.,fulltext,The relapse rate and the global brain atrophy rate were the primary outcomes of this study.,92.85714285714286
1569,inclusion of PwMS with an unassisted but limited walking competency (100–500 m),fulltext,inclusion of PwMS with an unassisted but limited walking competency (100–500 m),100.0
1569,Patients have been recruited at Ferrara University Hospital from patients who attend the Rehabilitation Outpatient Clinic for gait rehabilitation.,fulltext,Patients have been recruited at Ferrara University Hospital from patients who attend the Rehabilitation Outpatient Clinic for gait rehabilitation.,100.0
1569,"TOCT includes six workstations with five levels of complexity (step, slalom, tandem exercise, goals, obstacles, long step). PwMS exercised for 5 min in each one (3 min of activities and 2 min of rest).",fulltext,"TOCT includes six workstations with five levels of complexity (step, slalom, tandem exercise, goals, obstacles, long step). PwMS exercised for 5 min in each one (3 min of activities and 2 min of rest).",100.0
1569,"One session included up to three patients and lasted 120 min, five days/week for two weeks.",fulltext,"One session included up to three patients and lasted 120 min, five days/week for two weeks.",100.0
1569,"During TOCT, they received feedback (visual and auditory) from the physiotherapist.",fulltext,"During TOCT, they received feedback (visual and auditory) from the physiotherapist.",100.0
1569,"The blind evaluator, who did not supervise the training program, performed functional tests, questionnaires and instrumental measurements the week before treatment, the week after the end of the supervised-TOCT, after the 12-weeks home-based TOCT program.",fulltext,"The blind evaluator, who did not supervise the training program, performed functional tests, questionnaires and instrumental measurements the week before treatment, the week after the end of the supervised-TOCT, after the 12-weeks home-based TOCT program.",100.0
1569,The primary outcome measure was the 6-minute walking test (6MWT) for walking endurance,fulltext,The primary outcome measure was the 6-minute walking test (6MWT) for walking endurance,100.0
1570,"Inclusion criteria were as follows: Age between 14 – 50 yrs, definite diagnosis of MS based on clinical manifestations and performing MRI according to McDonald’s criteria, acceptance of the 24 month protocol by the patients, not being pregnant or lactating, history of having received a kind of β- interferon under the supervision of a neurologist in a period of no more than 30 days prior to the study.",fulltext,"the following criteria: Age between 14 – 50 yrs, definite diagnosis of MS based on clinical manifestations and performing MRI according to McDonald’s criteria, acceptance of the 24 month protocol by the patients, not being pregnant or lactating, history of having received a kind of βinterferon under the supervision of a neurologist in a period of no more than 30 days prior to th",92.05955334987593
1570,"At the end of 24 months the patients were again evaluated for EDSS, and the number of relapses for each patient was calculated (cases of pseudoexacerbation were not considered as relapse).",fulltext,"At the end of 24 months the patients were again evaluated for EDSS, and the number of relapses for each patient was calculated (cases of pseudoexacerbation were not considered as relapse).",100.0
1769,"Patients with multiple sclerosis were randomly selected into treated and control groups; only patients who could walk with or without walking aids were admitted to the trial, and these cases were initially assessed and scored during an inactive phase of the disease.",fulltext,"Patients with multiple sclerosis were randomly selected into treated and control groups; only patients who could walk with or without walking aids were admitted to the trial, and these cases were initially assessed and scored during an inactive phase of the disease.",100.0
1769,"In Manchester, patients who had relapsed in the previous eighteen months only were admitted to the trial.",fulltext,"In Manchester, patients who had relapsed in the previous eighteen months only were admitted to the trial.",100.0
1769,Patients with diabetes mellitus or hypertension or who gave a history of psychiatric illness or peptic ulcer were not admitted to the treated group.,fulltext,Patients with diabetes mellitus or hypertension or who gave a history of psychiatric illness or peptic ulcer were not admitted to the treated group.,100.0
1769,"This controlled study was started in 1963 in three cities-Belfast, Leeds, and Manchester.",fulltext,"This controlled study was started in 1963 in three citiesBelfast, Leeds, and Manchester.",98.87640449438202
1769,It could not be a double-blind study. A separate trial was carried out in the three centres using the same treatment and scoring methods.,fulltext,It could not be a doubleblind study. A separate trial was carried out in the three centres using the same treatment and scoring methods.,99.27007299270073
1769,"The treated group were given corticotrophin (’ Acthar ’ gel) in a dosage which varied between 15 and 25 units daily, potassium chloride orally, and a low-salt diet.",fulltext,"The treated group were given corticotrophin (’ Acthar ’ gel) in a dosage which varied between 15 and 25 units daily, potassium chloride orally, and a low-salt diet.",100.0
1769,"The dose of corticotrophin was adjusted to produce just enough "" mooning "" of the face to be appreciated by the physician in charge of the trial and the dose was not increased during a relapse.",fulltext,"The dose of corticotrophin was adjusted to produce just enough "" mooning "" of the face to be appreciated by the physician in charge of the trial and the dose was not increased during a relapse.",100.0
1769,Both treated and control groups were given aneurin 100 mg. by injection monthly.,fulltext,Both treated and control groups were given aneurin 100 mg. by injection monthly.,100.0
1769,When possible a glucose-tolerance test was carried out before corticotrophin was started.,fulltext,When possible a glucose-tolerance test was carried out before corticotrophin was started.,100.0
1769,All cases were seen at three-monthly intervals and scored on the Kurtzke (1961) scale; relapses lasting longer than twenty-four hours were also scored by a system in the three centres.,fulltext,All cases were seen at three-monthly intervals and scored on the Kurtzke (1961) scale; relapses lasting longer than twenty-four hours were also scored by a system in the three centres.,100.0
1769,"The treated group were weighed, their urine was tested, blood-pressure recorded, and blood analysed for electrolytes.",fulltext,"The treated group were weighed, their urine was tested, blood-pressure recorded, and blood analysed for electrolytes.",100.0
1769,"Again there was no evidence to show that corticotrophin prevented deterioration or reduced the number or severity of the relapses; nor was there any evidence that corticotrophin adversely affected the disease process, apart from side-effects due to the drug itself.",fulltext,"Again there was no evidence to show that corticotrophin prevented deterioration or reduced the number or severity of the relapses; nor was there any evidence that corticotrophin adversely affected the disease process, apart from side-effects due to the drug itself.",100.0
1769,"The total results were obtained by adding the results from the three cities; this was considered justifiable since the methods of selection, treatment, and scoring were essentially the same.",fulltext,"The total results were obtained by adding the results from the three cities; this was considered justifiable since the methods of selection, treatment, and scoring were essentially the same.",100.0
1770,"Only patients with a clinical or laboraton- supported definite diagnosis of MS according to the Poser criteria (6), suffering from a relapse, were included.",fulltext,"Only patients with a clinical or laboraton- supported definite diagnosis of MS according to the Poser criteria (6), suffering from a relapse, were included.",100.0
1770,Assessment of patients was performed by their own neurologist.,fulltext,Assessment of patients was performed by their own neurologist.,100.0
1770,"Three neurological departments in the Netherlands (University Hospital Groningen, Streekziekenhuis Almelo, Diaconessenhuis Meppel) participated in this study.",fulltext,"Three neurological departments in the Netherlands (University Hospital Groningen, Streekziekenhuis Almelo, Diaconessenhuis Meppel) participated in this study.",100.0
1770,"Three neurological departments in the Netherlands (University Hospital Groningen, Streekziekenhuis Almelo, Diaconessenhuis Meppel) participated in this study.",fulltext,"Three neurological departments in the Netherlands (University Hospital Groningen, Streekziekenhuis Almelo, Diaconessenhuis Meppel) participated in this study.",100.0
1770,"ACTH (100 units intramuscular, tapered over 12 weeks)",fulltext,"ACTH-treatment (100 units intramuscular, tapered over 12 weeks)",100.0
1770,"Follow-up was performed in the 6th and 12th week of treatment and 6, 9, and 12 months after the start of treatment.",fulltext,"Follow-up was performed in the 6th and 12th week of treatment and 6, 9, and 12 months after the start of treatment.",100.0
1770,"Assessment included: EDSS, FS, AI, ISS",fulltext,"Assessment included: EDSS, FS, AI, ISS",100.0
1770,"Three patients were withdrawn because of subsequent treatment with ACTH, corticosteroids or immunosuppressive drugs during the follow-up period.",fulltext,"Three patients were withdrawn because of subsequent treatment with ACTH, corticosteroids or immunosuppressive drugs during the follow-up period.",100.0
1771,"Eighty-six participants were recruited from Danish MS clinics (Aarhus University Hospital, Viborg Regional Hospital, Odense University Hospital, and the MS Clinic of Southern Jutland (Kolding)). For inclusion and exclusion criteria, see Langeskov-Christensen et al.",fulltext,"Eighty-six participants were recruited from Danish MS clinics (Aarhus University Hospital, Viborg Regional Hospital, Odense University Hospital, and the MS Clinic of Southern Jutland (Kolding)). For inclusion and exclusion criteria, see Langeskov-Christensen et al.",100.0
1771,"Based on the Z-scores, 37 pwMS (43%) were classified as cognitively impaired (22 participants in the PAE group, 15 participants in the waitlist group).",fulltext,"Based on the Z-scores, 37 pwMS (43%) were classified as cognitively impaired (22 participants in the PAE group, 15 participants in the waitlist group).",100.0
1771,"Eighty-six participants were recruited from Danish MS clinics (Aarhus University Hospital, Viborg Regional Hospital, Odense University Hospital, and the MS Clinic of Southern Jutland (Kolding)).",fulltext,"Eighty-six participants were recruited from Danish MS clinics (Aarhus University Hospital, Viborg Regional Hospital, Odense University Hospital, and the MS Clinic of Southern Jutland (Kolding)).",100.0
1771,"Supervised PAE sessions were conducted twice weekly during the 24 weeks, with one continuous and one interval exercise session performed each week.",fulltext,"Supervised PAE sessions were conducted twice weekly during the 24 weeks, with one continuous and one interval exercise session performed each week.",100.0
1771,"In brief, the session volume increased from 30 to 60 minutes during the intervention while the intensity increased from 65% to 95% of individual maximum heart rate (HRmax).",fulltext,"In brief, the session volume increased from 30 to 60 minutes during the intervention while the intensity increased from 65% to 95% of individual maximum heart rate (HRmax).",100.0
1771,"For further details on exercise modality options and the progressing volume and intensity of the exercise sessions, see Langeskov-Christensen et al.",fulltext,"For further details on exercise modality options and the progressing volume and intensity of the exercise sessions, see Langeskov-Christensen et al.",100.0
1771,Twelve pwMS were unable to adhere with the prescribed intensity of 90%–95% of HRmax during the last 8 weeks of the intervention (mean intensity for the 12 subjects = 87.8% of HRmax).,fulltext,Twelve pwMS were unable to adhere with the prescribed intensity of 90%–95% of HRmax during the last 8 weeks of the intervention (mean intensity for the 12 subjects = 87.8% of HRmax).,100.0
1771,"At baseline (T0), after 24 (T24) and after 48 (T48) weeks, participants performed the BRB-N, the Major Depression Inventory (MDI), and a cardiorespiratory fitness test (VO2-max test). Each test session was separated by at least 48 hours from the last exercise bout.",fulltext,"At baseline (T0), after 24 (T24) and after 48 (T48) weeks, participants performed the BRB-N, the Major Depression Inventory (MDI), and a cardiorespiratory fitness test (VO2-max test). Each test session was separated by at least 48 hours from the last exercise bout.",100.0
1771,"Assessments included the Brief Repeatable Battery of Neuropsychological tests (BRB-N), self-reported mood, and cardiorespiratory fitness.",fulltext,"Assessments included the Brief Repeatable Battery of Neuropsychological tests (BRB-N), self-reported mood, and cardiorespiratory fitness.",100.0
1771,All longitudinal data for the total group and the cognitively impaired subgroup were analyzed using an intention-to-treat linear mixed effects model with time and group as the factors of interest.,fulltext,All longitudinal data for the total group and the cognitively impaired subgroup were analyzed using an intention-to-treat linear mixed effects model with time and group as the factors of interest.,100.0
1772,Patients were required to have received a single iDMT (except natalizumab) continuously for at least 6 months prior to study initiation and to be candidates for therapy change.,fulltext,Patients were required to have received a single iDMT (except natalizumab) continuously for at least 6 months prior to study initiation and to be candidates for therapy change.,100.0
1772,"In the case of Canadian patients, only those with relapsing–remitting MS and who had an inadequate response to, or were unable to tolerate, one or more therapies for MS were eligible.",fulltext,"In the case of Canadian patients, only those with relapsing–remitting MS and who had an inadequate response to, or were unable to tolerate, one or more therapies for MS were eligible.",100.0
1772,"The protocol and informed consent form were reviewed and approved by an institutional review board (Quorum Review) at each study center, and every patient provided written informed consent.",fulltext,"The protocol and informed consent form were reviewed and approved by an institutional review board (Quorum Review) at each study center, and every patient provided written informed consent.",100.0
1772,"EPOC was a 6-month, randomized, open-label, multicenter, phase 4 study conducted in the USA and Canada.",fulltext,"EPOC was a 6-month, randomized, open-label, multicenter, phase 4 study conducted in the USA and Canada.",100.0
1772,"Patients were randomized 3:1 to switch to fingolimod (FTY720; Gilenya®, Novartis Pharma AG, Basel, Switzerland) 0.5 mg or remain on/switch to an iDMT for 6 months with no intervening washout period.",fulltext,"Patients were randomized 3:1 to switch to fingolimod (FTY720; Gilenya®, Novartis Pharma AG, Basel, Switzerland) 0.5 mg or remain on/switch to an iDMT for 6 months with no intervening washout period.",100.0
1772,"The primary analysis evaluated two groups, namely fingolimod versus any iDMT. Patients randomized to the iDMT group either remained on the same therapy or, following consultation with a physician, were switched immediately to another approved iDMT.",fulltext,"The primary analysis evaluated two groups, namely fingolimod versus any iDMT. Patients randomized to the iDMT group either remained on the same therapy or, following consultation with a physician, were switched immediately to another approved iDMT.",100.0
1772,The primary endpoint was the change in Treatment Satisfaction Questionnaire for Medication (TSQM) Global Satisfaction score from baseline to 6 months [15].,fulltext, The primary post hoc study endpoint was the least-squares mean (LSM) change in Treatment Satisfaction Questionnaire for Medication (TSQM) Global Satisfaction score from baseline to 6 months [15,98.70967741935483
1772,Missing data were imputed using the last observation carried forward.,fulltext,Missing data were imputed using the last observation carried forward.,100.0
1773,Forty-two relapsing-remitting MS patients (23 women and 19 men) volunteered to participate in the study.,fulltext,Forty-two relapsing-remitting MS patients (23 women and 19 men) volunteered to participate in the study.,100.0
1773,"The patient inclusion criteria included a confirmed disease diagnosis by a neurologist, according to Mc-Donald criteria (McDonald, 2001); ability to walk (with or without aid) at least 20 m without rest; absence of other diseases that might have affected muscle function.",fulltext,"The patient inclusion criteria included a confirmed disease diagnosis by a neurologist, according to Mc-Donald criteria (McDonald, 2001); ability to walk (with or without aid) at least 20 m without rest; absence of other diseases that might have affected muscle function.",100.0
1773,"After a group meeting where the details of the investigation were described to the patients, including possible risks and discomfort associated to the intervention, a formal invitation to take part in the study was offered.",fulltext,"After a group meeting where the details of the investigation were described to the patients, including possible risks and discomfort associated to the intervention, a formal invitation to take part in the study was offered.",100.0
1773,All training sessions took place in MS rehabilitation centers and the patients were continuously supervised by physical therapists.,fulltext,All training sessions took place in MS rehabilitation centers and the patients were continuously supervised by physical therapists.,100.0
1773,"Subjects performed coupled concentric-eccentric bilateral seated knee extension training using a weight stack machine (BH® Fitness Nevada Pro-T, Spain) twice per week during 12 weeks, with at least 48 h of rest between sessions.",fulltext,"Subjects performed coupled concentric-eccentric bilateral seated knee extension training using a weight stack machine (BH® Fitness Nevada Pro-T, Spain) twice per week during 12 weeks, with at least 48 h of rest between sessions.",100.0
1773,"After a standardized cycling warm-up, and one set of 5 repetitions (reps) with a light load, participants performed 3 sets of 8–12 reps with a load that was progressively increased from 35 to 70% of MVIC through the training period (Table 2). Recovery time between sets was 3 minutes.",fulltext,"After a standardized cycling warm-up, and one set of 5 repetitions (reps) with a light load, participants performed 3 sets of 8–12 reps with a load that was progressively increased from 35 to 70% of MVIC through the training period (Table 2). Recovery time between sets was 3 minutes.",100.0
1773,All training sessions took place in MS rehabilitation centers and the patients were continuously supervised by physical therapists.,fulltext,All training sessions took place in MS rehabilitation centers and the patients were continuously supervised by physical therapists.,100.0
1773,"Testing was performed on three different occasions: before (week 0) and after (week 12) the training program, and after the detraining period (week 24).",fulltext,"Testing was performed on three different occasions: before (week 0) and after (week 12) the training program, and after the detraining period (week 24).",100.0
1773,"Maximal voluntary isometric contraction (MVIC), maximal torque, average muscle power and muscle endurance.",fulltext,"maximal voluntary isometric contraction (MVIC), maximal torque, average muscle power and muscle endurance.",100.0
648,"Pregnant women were eligible if they were to undergo delivery by lower segment caesarean section through a transverse abdominal incision, irrespective of fever in labour, gestational age, or multiple pregnancies.",fulltext,"Pregnant women were eligible if they were to undergo delivery by lower segment caesarean section through a transverse abdominal incision, irrespective of fever in labour, gestational age, or multiple pregnancies.",100.0
648,"Each participating site, advised by their research ethics committee, decided how to provide trial information to women and seek informed consent. Information leaflets were made available, in appropriate languages, which explained the trial objectives, the process of trial entry, and follow-up. The trial was discussed with all eligible women and their partners and relatives as appropriate. If the woman agreed to participate, she signed a formal consent form or used the method of recording consent permitted in that setting (eg, a thumb print).",fulltext,"Each participating site, advised by their research ethics committee, decided how to provide trial information to women and seek informed consent. Information leaflets were made available, in appropriate languages, which explained the trial objectives, the process of trial entry, and follow-up. The trial was discussed with all eligible women and their partners and relatives as appropriate. If the woman agreed to participate, she signed a formal consent form or used the method of recording consent permitted in that setting (eg, a thumb print).",100.0
648,"CORONIS was undertaken at 19 sites in Argentina, Chile, Ghana, India, Kenya, Pakistan, and Sudan.",fulltext,"CORONIS was undertaken at 19 sites in Argentina, Chile, Ghana, India, Kenya, Pakistan, and Sudan.",100.0
648,All non-allocated surgical elements and all other aspects of the caesarean section procedure were undertaken at the discretion of the surgeon.,fulltext,All non-allocated surgical elements and all other aspects of the caesarean section procedure were undertaken at the discretion of the surgeon.,100.0
648,"Compliance with all the allocated interventions was high, 87% overall.",fulltext,"Compliance with all the allocated interventions was high, 87% overall.",100.0
648,"Data were collected at trial entry, immediately after surgery, at hospital discharge (including hospital transfer or death), and at about 6 weeks after delivery.",fulltext,"Data were collected at trial entry, immediately after surgery, at hospital discharge (including hospital transfer or death), and at about 6 weeks after delivery.",100.0
648,"The primary outcome was a composite of death, maternal infectious morbidity, further operative procedures, or blood transfusion of more than 1 unit of whole blood or packed cells up to the 6-week follow-up visit.",fulltext,"The primary outcome was a composite of death, maternal infectious morbidity, further operative procedures, or blood transfusion of more than 1 unit of whole blood or packed cells up to the 6-week follow-up visit.",100.0
648,"Women were analysed in the groups into which they were allocated; for example, comparing women allocated to blunt abdominal entry with those allocated to sharp abdominal entry, regardless of what interventions they actually received.",fulltext,"Women were analysed in the groups into which they were allocated; for example, comparing women allocated to blunt abdominal entry with those allocated to sharp abdominal entry, regardless of what interventions they actually received.",100.0
650,Patients with a clinically established diagnosis of type 2 diabetes mellitus were sent a letter by their GPs to introduce the SMS project.,fulltext,Patients with a clinically established diagnosis of type 2 diabetes mellitus were sent a letter by their GPs to introduce the SMS project.,100.0
650,Patients with score DFT >4 and DS >3 were eligible for trial participation.,fulltext,Patients with score DFT >4 and DS >3 were eligible for trial participation.,100.0
650,Patients were sent a letter by their GPs to introduce the SMS project.,fulltext,s were sent a letter by their GPs to introduce the SMS project.,90.0
650,The enclosed self-administered questionnaire consisted of the screening instruments that intervention PNs would also apply for SMS in their routine practice.,fulltext,The enclosed self-administered questionnaire consisted of the screening instruments that intervention PNs would also apply for SMS in their routine practice.,100.0
650,All the family practices of one regional organisation of GPs (a so-called ‘care group’) in the South of the Netherlands were eligible to participate in the study.,fulltext,All the family practices of one regional organisation of GPs (a so-called ‘care group’) in the South of the Netherlands were eligible to participate in the study.,100.0
650,PNs in the intervention arm were trained to integrate the detection and follow-up phase of SMS into their daily practice.,fulltext,PNs in the intervention arm were trained to integrate the detection and follow-up phase of SMS into their daily practice.,100.0
650,Financial reimbursement for the extra time spent on SMS was added to the bundled payment arrangement for diabetes care.,fulltext,Financial reimbursement for the extra time spent on SMS was added to the bundled payment arrangement for diabetes care.,100.0
650,"PNs supported patients in the processes of defining problems and finding solutions themselves, by applying problem-solving and reattribution techniques.",fulltext,"PNs supported patients in the processes of defining problems and finding solutions themselves, by applying problem-solving and reattribution techniques.",100.0
650,"Patients could use information from a diary in which they recorded symptoms, thoughts, worries, feelings, and behaviour.",fulltext,"Patients could use information from a diary in which they recorded symptoms, thoughts, worries, feelings, and behaviour.",100.0
650,Outcomes were measured at baseline and at 4-month and 12-month follow-ups.,fulltext,Outcomes were measured at baseline and at 4-month and 12-month follow-ups.,100.0
650,The effect of SMS on patients’ daily functioning was measured by means of the DFT.,fulltext,The effect of SMS on patients’ daily functioning was measured by means of the DFT.,100.0
651,Eligible primary care patients 12 to 80 years of age had impaired asthma-related quality of life (Mini Asthma Quality of Life Questionnaire [MiniAQLQ] score ≤6) or inadequate asthma control (Asthma Control Questionnaire [ACQ] score ≥1).,fulltext,Eligible primary care patients 12 to 80 years of age had impaired asthma-related quality of life (Mini Asthma Quality of Life Questionnaire [MiniAQLQ] score ≤6) or inadequate asthma control (Asthma Control Questionnaire [ACQ] score ≥1).,100.0
651,"Other eligibility criteria for both trials included, at screening, a peak expiratory flow (PEF) greater than 50% of the predicted value after an inhaled beta2-agonist had been withheld for 4 hours or longer and, at the baseline visit, evidence of impaired asthma-related quality of life (a score ≤6 on the Mini Asthma Quality of Life Questionnaire25,26 [MiniAQLQ]) or impaired asthma control (a score ≥1 on the Asthma Control Questionnaire27 [ACQ]).",fulltext,"Other eligibility criteria for both trials included, at screening, a peak expiratory flow (PEF) greater than 50% of the predicted value after an inhaled beta2-agonist had been withheld for 4 hours or longer and, at the baseline visit, evidence of impaired asthma-related quality of life (a score ≤6 on the Mini Asthma Quality of Life Questionnaire25,26 [MiniAQLQ]) or impaired asthma control (a score ≥1 on the Asthma Control Questionnaire27 [ACQ]).",100.0
651,Main exclusion criteria were prior treatment within 12 weeks with an inhaled glucocorticoid or LTRA (in the first-line controller therapy trial) or LTRA or LABA (in the add-on therapy trial).,fulltext,Main exclusion criteria were prior treatment within 12 weeks with an inhaled glucocorticoid or LTRA (in the first-line controller therapy trial) or LTRA or LABA (in the add-on therapy trial).,100.0
651,"Study enrollment is shown in Fig. E1 and E2 in the Supplementary Appendix; additional results are detailed in Tables E1 through E28 in the Supplementary Appendix. In both trials, the reason for most exclusions after randomization was a missing MiniAQLQ or ACQ score or a baseline score that was not within the specified range for eligibility.",fulltext,"Study enrollment is shown in Fig. E1 and E2 in the Supplementary Appendix; additional results are detailed in Tables E1 through E28 in the Supplementary Appendix. In both trials, the reason for most exclusions after randomization was a missing MiniAQLQ or ACQ score or a baseline score that was not within the specified range for eligibility.",100.0
651,"The trials were conducted at 53 primary care practices in the United Kingdom, enrolled patients 12 to 80 years of age with a physician's diagnosis of asthma.",fulltext,"The two trials, which were conducted at 53 primary care practices in the United Kingdom, enrolled patients 12 to 80 years of age with a physician's diagnosis of asthma.",100.0
651,"The two trials, which were conducted at 53 primary care practices in the United Kingdom, enrolled patients 12 to 80 years of age with a physician's diagnosis of asthma.",fulltext,"The two trials, which were conducted at 53 primary care practices in the United Kingdom, enrolled patients 12 to 80 years of age with a physician's diagnosis of asthma.",100.0
651,"Practice staffs were asked to provide each patient with a written individualized asthma-action plan. For each of the assigned treatments, choices of individual drugs and devices were made according to normal clinical practice and British asthma guidelines.",fulltext,"Practice staffs were asked to provide each patient with a written individualized asthma-action plan. For each of the assigned treatments, choices of individual drugs and devices were made according to normal clinical practice and British asthma guidelines.",100.0
651,Patients who withdrew from the study continued to receive care from their usual clinician.,fulltext,Patients who withdrew from the study continued to receive care from their usual clinician.,100.0
651,"An automated, computerized telephone center randomly assigned eligible patients at baseline to open-label treatment with either an LTRA (montelukast or zafirlukast) or an inhaled glucocorticoid (beclomethasone, budesonide, or fluticasone) in the first-line controller therapy trial and with either an LTRA or LABA (salmeterol or formoterol) together with an inhaled glucocorticoid in the add-on therapy trial.",fulltext,"An automated, computerized telephone center randomly assigned eligible patients at baseline to open-label treatment with either an LTRA (montelukast or zafirlukast) or an inhaled glucocorticoid (beclomethasone, budesonide, or fluticasone) in the first-line controller therapy trial and with either an LTRA or LABA (salmeterol or formoterol) together with an inhaled glucocorticoid in the add-on therapy trial.",100.0
651,"The protocol discouraged substantial treatment changes between randomization and the 2-month visit. If a patient required a disallowed asthma medication, this fact was noted, and the patient remained in the study.",fulltext,"The protocol discouraged substantial treatment changes between randomization and the 2-month visit. If a patient required a disallowed asthma medication, this fact was noted, and the patient remained in the study.",100.0
651,"Assessments by telephone or in the clinic were scheduled at months 2, 6, 12, 18, and 24.",fulltext,"Assessments by telephone or in the clinic were scheduled at months 2, 6, 12, 18, and 24.",100.0
651,"Data collection and statistical analyses were performed by study personnel who were unaware of the treatment assignments; questionnaire-based data were collected under blinded conditions, and routine practice data (including a history of exacerbations) were extracted with the use of dedicated software.",fulltext,"Data collection and statistical analyses were performed by study personnel who were unaware of the treatment assignments; questionnaire-based data were collected under blinded conditions, and routine practice data (including a history of exacerbations) were extracted with the use of dedicated software.",100.0
651,The primary outcome measure was the MiniAQLQ score.,fulltext,The primary outcome measure was the MiniAQLQ score.,100.0
651,The primary effectiveness analysis was an intention-to-treat analysis of the MiniAQLQ score at 2 months (the primary time point) and at 2 years.,fulltext,The primary effectiveness analysis was an intention-to-treat analysis of the MiniAQLQ score at 2 months (the primary time point) and at 2 years.,100.0
655,"Patient selection criteria were having a diagnosis of moderate-to-severe COPD (a Body mass index, Airflow obstruction, dyspnoea and Exercise capacity [BODE] index score of 3–7) according to international guidelines and having been clinically stable for the previous 4 weeks.",fulltext,"Patient selection criteria were having a diagnosis of moderate-to-severe COPD (a Body mass index, Airflow obstruction, dyspnoea and Exercise capacity [BODE] index score of 3–7) according to international guidelines9 and having been clinically stable for the previous 4 weeks ",100.0
655,"Overall, 134 patients were screened and 94 were eventually randomized into two groups: 48 to the CG and 46 to the IG.",fulltext,"Overall, 134 patients were screened and 94 were eventually randomized into two groups: 48 to the CG and 46 to the IG.",100.0
655,"Recruited patients (recruitment visit, −1) attended an initial 8-week outpatient-based PR programme conducted in each hospital rehabilitation department.",fulltext,"Recruited patients (recruitment visit, −1) attended an initial 8-week outpatient-based PR programme conducted in each hospital rehabilitation department.",100.0
655,This was a multicentre open-label pragmatic parallel-group randomized clinical trial involving 13 hospitals and was conducted between 2014 and 2017.,fulltext,This was a multicentre open-label pragmatic parallel-group randomized clinical trial involving 13 hospitals and was conducted between 2014 and 2017.,100.0
655,"Patients in the IG were asked to continue at home with a similar training schedule to that completed in the hospital. They were provided with, for the 12-month follow-up period, a telerehabilitation kit (mobile phone, pulse oximeter, dumbbells and exercise bicycle) along with a user guide with detailed instructions on the use of the mobile device to deliver data collected to the web-based platform after completion of each scheduled session.",fulltext,"Patients in the IG were asked to continue at home with a similar training schedule to that completed in the hospital. They were provided with, for the 12-month follow-up period, a telerehabilitation kit (mobile phone, pulse oximeter, dumbbells and exercise bicycle) along with a user guide with detailed instructions on the use of the mobile device to deliver data collected to the web-based platform after completion of each scheduled session.",100.0
655,"They were provided with, for the 12-month follow-up period, a telerehabilitation kit (mobile phone, pulse oximeter, dumbbells and exercise bicycle) along with a user guide with detailed instructions on the use of the mobile device to deliver data collected to the web-based platform after completion of each scheduled session.",fulltext,"They were provided with, for the 12-month follow-up period, a telerehabilitation kit (mobile phone, pulse oximeter, dumbbells and exercise bicycle) along with a user guide with detailed instructions on the use of the mobile device to deliver data collected to the web-based platform after completion of each scheduled session.",100.0
655,"Patients in the CG received usual care, that is, they were advised to exercise regularly (at least walking for 1 hour a day) and provided with general educational material, following current clinical practice at participating sites.",fulltext,"Patients in the CG received usual care, that is, they were advised to exercise regularly (at least walking for 1 hour a day) and provided with general educational material, following current clinical practice at participating sites.",100.0
655,"After the randomization visit, follow-up appointments were arranged for both groups at 3, 9 and 12 months.",fulltext,"After the randomization visit, follow-up appointments were arranged for both groups at 3, 9 and 12 months.",100.0
655,Exercise tolerance (the ability to sustain exercise) was assessed using distance covered in the 6MWT.,fulltext,Exercise tolerance (the ability to sustain exercise) was assessed using distance covered in the 6MWT.,100.0
655,All patients were analyzed in the group to which they were randomized.,fulltext,All patients were analyzed in the group to which they were randomized.,100.0
655,Missing values were not imputed. All patients were analyzed in the group to which they were randomized.,fulltext,Missing values were not imputed. All patients were analyzed in the group to which they were randomized.,100.0
657,"Inclusion criteria were as follows: (1) diagnosed with MS in accordance with the McDonald criteria27; (2) registered at the MS outpatient clinic; (3) living in 1 of 6 selected municipalities; (4) aged 18 years or older; (5) capable of providing signed written informed consent; and (6) EDSS score between 1 and 6.5 (1 = minor disability, 6.5 = able to walk 20 m with or without a walking aid). The exclusion criteria were as follows: (1) pregnancy at time of examination; (2) exacerbation in the previous 2 weeks before enrollment; and (3) other acute conditions compromising balance.",fulltext,"inclusion criteria were as follows: (1) diagnosed with MS in accordance with the McDonald criteria27; (2) registered at the MS outpatient clinic; (3) living in 1 of 6 selected municipalities; (4) aged 18 years or older; (5) capable of providing signed written informed consent; and (6) EDSS score between 1 and 6.5 (1 = minor disability, 6.5 = able to walk 20 m with or without a walking aid). The exclusion criteria were as follows: (1) pregnancy at time of examination; (2) exacerbation in the previous 2 weeks before enrollment; and (3) other acute conditions compromising balance.",100.0
657,"Among the 93 individuals who consented to participate, 13 were not included: 5 could not commit the time, 3 scored 0 on the EDSS, 2 did not attend the baseline assessment, 1 was waiting for heart surgery, 1 was pregnant, and 1 had moved out of the catchment area.",fulltext,"Among the 93 individuals who consented to participate, 13 were not included: 5 could not commit the time, 3 scored 0 on the EDSS, 2 did not attend the baseline assessment, 1 was waiting for heart surgery, 1 was pregnant, and 1 had moved out of the catchment area.",100.0
657,"In August 2015, 1 of the MS nurses at the Department of Neurology, Nordland Hospital Trust in Bodø, Norway, sent out invitation letters with a consent form to 160 persons with MS who were registered at the MS outpatient clinic, had EDSS scores of 0 to 7, and lived in 1 of the 6 municipalities included in the study.",fulltext,"In August 2015, 1 of the MS nurses at the Department of Neurology, Nordland Hospital Trust in Bodø, Norway, sent out invitation letters with a consent form to 160 persons with MS who were registered at the MS outpatient clinic, had EDSS scores of 0 to 7, and lived in 1 of the 6 municipalities included in the study.",100.0
657,"To ensure maximum patient enrollment, 1 reminder letter was sent out to the nonresponders.",fulltext,"To ensure maximum patient enrollment, 1 reminder letter was sent out to the nonresponders.",100.0
657,The GroupCoreDIST intervention was conducted by 6 physical therapists in 6 municipalities in Norway.,fulltext,The GroupCoreDIST intervention was conducted by 6 physical therapists in 6 municipalities in Norway.,100.0
657,Six neurological physical therapists conducted the intervention after being trained in GroupCoreDIST for 5 days.,fulltext,Six neurological physical therapists conducted the intervention after being trained in GroupCoreDIST for 5 days.,100.0
657,"The physical therapists conducted an individual clinical examination of each participant. The examinations were followed by group sessions, in which the physical therapists chose from 33 exercises, all with 5 levels of difficulty to address each individual's impairments underlying his or her balance disturbance.",fulltext,"The physical therapists conducted an individual clinical examination of each participant. The examinations were followed by group sessions, in which the physical therapists chose from 33 exercises, all with 5 levels of difficulty to address each individual's impairments underlying his or her balance disturbance.",100.0
657,"The physical therapists individualized the exercises by tailoring them according to each individual's symptoms, disability level, and general well-being, and they intensified the exercises by increasing number of repetitions, level of difficulty, and/or by adding motor-cognitive dual tasks as movement quality improved.",fulltext,"The physical therapists individualized the exercises by tailoring them according to each individual's symptoms, disability level, and general well-being, and they intensified the exercises by increasing number of repetitions, level of difficulty, and/or by adding motor-cognitive dual tasks as movement quality improved.",100.0
657,Participants in the intervention group were encouraged not to seek any physical therapy other than GroupCoreDIST during the 6 weeks of the intervention.,fulltext,Participants in the intervention group were encouraged not to seek any physical therapy other than GroupCoreDIST during the 6 weeks of the intervention.,100.0
657,"Assessments were conducted at baseline and at weeks 7, 18, and 30.",fulltext,"Assessments were conducted at baseline and at weeks 7, 18, and 30.",100.0
657,Two assessors masked with regard to the group allocation carried out the assessments.,fulltext,Two assessors masked with regard to the group allocation carried out the assessments.,100.0
657,"The outcome measures were the Trunk Impairment Scale–Norwegian Version (TIS-NV), the Mini Balance Evaluation Systems Test (Mini-BESTest), and the Patient Global Impression of Change–Balance (PGIC-Balance).",fulltext,"The outcome measures were the Trunk Impairment Scale–Norwegian Version (TIS-NV), the Mini Balance Evaluation Systems Test (Mini-BESTest), and the Patient Global Impression of Change–Balance (PGIC-Balance).",100.0
657,"To examine possible differences between groups over time, we performed an intention-to-treat analysis using repeated-measures mixed models in IBM SPSS Version 24.",fulltext,"To examine possible differences between groups over time, we performed an intention-to-treat analysis using repeated-measures mixed models in IBM SPSS Version 24.",100.0
662,"Inclusion criteria were diagnosis of PPMS or SPMS, Internet access and some level of distress determined by a score of 3 or greater on the General Health Questionnaire (GHQ-12).",fulltext,"Inclusion criteria were diagnosis of PPMS or SPMS, Internet access and some level of distress determined by a score of 3 or greater on the General Health Questionnaire (GHQ-12).",100.0
662,"Exclusion criteria were severe cognitive impairment, as determined by a score of 20 or smaller on the Telephone Interview for Cognitive Status-Modified (TICS-M) and high suicide risk, as assessed by a score of 20 or greater on the Clinical Outcome of Routine Evaluation (CORE-10).",fulltext,"Exclusion criteria were severe cognitive impairment, as determined by a score of 20 or smaller on the Telephone Interview for Cognitive Status-Modified (TICS-M)19 and high suicide risk, as assessed by a score of 20 or greater on the Clinical Outcome of Routine Evaluation (CORE-10).",100.0
662,Recruitment took place between December 2012 and May 2013. We administered the screening questionnaires via telephone.,fulltext,Recruitment took place between December 2012 and May 2013. We administered the screening questionnaires via telephone.,100.0
662,"Reasons for not attending included: medical appointments, planned holidays, pain/fatigue and technical problems, e.g. computer virus, stolen computer, problems with audio.",fulltext,"Reasons for not attending included: medical appointments, planned holidays, pain/fatigue and technical problems, e.g. computer virus, stolen computer, problems with audio.",100.0
662,We delivered the programme in eight hour-long sessions over an eight-week period via Skype video conferences.,fulltext,We delivered the programme in eight hour-long sessions over an eight-week period via Skype video conferences.,100.0
662,"AB, a health psychologist, facilitated the courses. AB was supervised by PC, a clinical psychologist and expert mindfulness practitioner.",fulltext,"AB, a health psychologist, facilitated the courses. AB was supervised by PC, a clinical psychologist and expert mindfulness practitioner.",100.0
662,"The format and manual for the mindfulness group, including length of sessions and individual mindfulness practices, were developed in partnership with patients with MS through initial experimental case studies.",fulltext,"The format and manual for the mindfulness group, including length of sessions and individual mindfulness practices, were developed in partnership with patients with MS through initial experimental case studies.",100.0
662,"We restricted the number of participants to five for each group based on Skype user guidance, which suggests the quality of videoconferences drops with more than this number.",fulltext,"We restricted the number of participants to five for each group based on Skype user guidance, which suggests the quality of videoconferences drops with more than this number.",100.0
662,"The eight chapters, one for each session, introduced key mindfulness concepts, addressed issues common to progressive MS, and described homework for the week ahead.",fulltext,"The eight chapters, one for each session, introduced key mindfulness concepts, addressed issues common to progressive MS, and described homework for the week ahead.",100.0
662,"Participants were encouraged to keep a diary of home practice, but, in fact, very few did record it.",fulltext,"Participants were encouraged to keep a diary of home practice, but, in fact, very few did record it.",100.0
662,Assessments occurred between January 2013 and October 2013. The blinded assessor (SW) notified participants by email when questionnaires were due.,fulltext,Assessments occurred between January 2013 and October 2013. The blinded assessor (SW) notified participants by email when questionnaires were due.,100.0
662,"In the waiting-list group, two participants (9.5%) at post-intervention and three (14.3%) at three-month follow-up failed to complete the questionnaire. In the mindfulness group, two participants (10.5%) did not complete the post-intervention questionnaires and four participants (21%) the three-month follow-up questionnaires.",fulltext,"In the waiting-list group, two participants (9.5%) at post-intervention and three (14.3%) at three-month follow-up failed to complete the questionnaire. In the mindfulness group, two participants (10.5%) did not complete the post-intervention questionnaires and four participants (21%) the three-month follow-up questionnaires.",100.0
662,The GHQ is uncontaminated by the experience of MS-related somatic symptoms and is the most treatment-responsive measure of psychological distress in MS.,fulltext,The GHQ is uncontaminated by the experience of MS-related somatic symptoms and is the most treatment-responsive measure of psychological distress in MS.,100.0
662,Higher scores on this scale represent high distress.,fulltext,Higher scores on this scale represent high distress.,100.0
662,We conducted all group comparisons on an intention-to-treat basis where we analysed participants in the group to which they were randomised.,fulltext,We conducted all group comparisons on an intention-to-treat basis where we analysed participants in the group to which they were randomised.,100.0
663,"Participants were included from September 2016 to October 2018, after being invited via seven MS clinics (specified in “Acknowledgements” section) and targeted advertisements sent out via the Danish MS Society.",fulltext,"Participants were included from September 2016 to October 2018, after being invited via seven MS clinics (specified in “Acknowledgements” section) and targeted advertisements sent out via the Danish MS Society.",100.0
663,"The inclusion criteria were as follows: age > 18, confirmed diagnosis of MS, Expanded Disability Status Scale (EDSS): 2.0–6.5, Six Spot Step Test (SSST) score > 8 seconds or Timed 25-Foot Walk (T25FW) > 5 seconds, relapse-free within the past 8 weeks, and no adjustment of disease-modifying medication or medication that affects gait performance and spasticity within the past 8 weeks.",fulltext,"The inclusion criteria were as follows: age > 18, confirmed diagnosis of MS, Expanded Disability Status Scale (EDSS): 2.0–6.5, Six Spot Step Test (SSST) score > 8 seconds or Timed 25-Foot Walk (T25FW) > 5 seconds, relapse-free within the past 8 weeks, and no adjustment of disease-modifying medication or medication that affects gait performance and spasticity within the past 8 weeks.",100.0
663,"Exclusion criteria were as follows: co-morbidity in terms of cognitive disorders or alcohol abuse (based on clinical judgment), pathologies that did not allow systematic PRT >1 session/week within the last 3 months.",fulltext,"Exclusion criteria were as follows: co-morbidity in terms of cognitive disorders or alcohol abuse (based on clinical judgment), pathologies that did not allow systematic PRT >1 session/week within the last 3 months.",100.0
663,"Participants were included from September 2016 to October 2018, after being invited via seven MS clinics (specified in “Acknowledgements” section) and targeted advertisements sent out via the Danish MS Society.",fulltext,"Participants were included from September 2016 to October 2018, after being invited via seven MS clinics (specified in “Acknowledgements” section) and targeted advertisements sent out via the Danish MS Society.",100.0
663,"Analyses were carried out as intention-to-treat, where all participants who completed the baseline assessment were included regardless of their adherence to the allocated intervention.",fulltext,"Analyses were carried out as intention-to-treat, where all participants who completed the baseline assessment were included regardless of their adherence to the allocated intervention.",100.0
664,"The inclusion criteria for the trial were clinical diagnosis of MS, as defined by the modified McDonald criteria, with an Expanded Disability Status Scale (EDSS) score of 1.0–6.5, and able to walk a 10-metre distance; aged 18–65 years; clinically stable for at least four weeks prior to entering the study; physically able to participate in exercise three times per week; able to provide written informed consent.",fulltext,"The inclusion criteria for the trial were clinical diagnosis of MS, as defined by the modified McDonald criteria,9 with an Expanded Disability Status Scale (EDSS) score of 1.0–6.5, and able to walk a 10-metre distance; aged 18–65 years; clinically stable for at least four weeks prior to entering the study; physically able to participate in exercise three times per week; able to provide written informed consent.",100.0
664,A total of 120 PwMS were recruited via the Sheffield MS Clinic and flyers/community adverts displayed at the local South Yorkshire MS Society branches.,fulltext,A total of 120 PwMS were recruited via the Sheffield MS Clinic and flyers/community adverts displayed at the local South Yorkshire MS Society branches.,100.0
664,Many eligible PwMS declined to take part in the study without giving a reason (N = 126; 66%) and a more comprehensive understanding of the barriers and facilitators to exercise in PwMS could be used to inform the design of future programmes.,fulltext,Many eligible PwMS declined to take part in the study without giving a reason (N = 126; 66%) and a more comprehensive understanding of the barriers and facilitators to exercise in PwMS could be used to inform the design of future programmes.,100.0
664,"During weeks 1–6, participants attended two supervised sessions per week at a university exercise research facility and engaged in one additional self-directed exercise session in their home environment.",fulltext,"During weeks 1–6, participants attended two supervised sessions per week at a university exercise research facility and engaged in one additional self-directed exercise session in their home environment.",100.0
664,"The supervised exercise sessions incorporated cognitive-behavioural techniques (e.g. goal setting, finding social support, understanding the costs/benefits of exercise, etc.) to promote long-term participation in physical activity.",fulltext,"The supervised exercise sessions incorporated cognitive-behavioural techniques (e.g. goal setting, finding social support, understanding the costs/benefits of exercise, etc.) to promote long-term participation in physical activity.",100.0
664,"The home-exercise sessions were intended to mirror the supervised sessions in terms of intensity and duration of aerobic exercise, and also included tailored exercises for strength, flexibility and balance.",fulltext,"The home-exercise sessions were intended to mirror the supervised sessions in terms of intensity and duration of aerobic exercise, and also included tailored exercises for strength, flexibility and balance.",100.0
664,"Using the Transtheoretical Model as a guiding framework, this aspect of the intervention was aimed at equipping PwMS with the skills, knowledge and confidence to engage in a more physically active lifestyle.",fulltext,"Using the Transtheoretical Model13 as a guiding framework, this aspect of the intervention was aimed at equipping PwMS with the skills, knowledge and confidence to engage in a more physically active lifestyle.",100.0
664,Outcomes were blindly assessed by an experienced researcher not directly involved with the day-to-day running of the trial.,fulltext,Outcomes were blindly assessed by an experienced researcher not directly involved with the day-to-day running of the trial.,100.0
664,The primary outcome was self-reported exercise behaviour at three months using the Godin Leisure Time Exercise Questionnaire (GLTEQ).,fulltext,The primary outcome was self-reported exercise behaviour at three months using the Godin Leisure Time Exercise Questionnaire (GLTEQ).,100.0
664,"All analyses were by intention to treat, whereby participants were analysed in the arm to which they were randomised irrespective of whether they complied with the intervention.",fulltext,"All analyses were by intention to treat, whereby participants were analysed in the arm to which they were randomised irrespective of whether they complied with the intervention.",100.0
665,"Inclusion criteria were: age of 18 years or above; BDI score of at least 14 on two consecutive occasions and no treatment from psychologist, psychotherapist or psychiatrist within the last three months.",fulltext,"Inclusion criteria were: age of 18 years or above; BDI score of at least 14 on two consecutive occasions and no treatment from psychologist, psychotherapist or psychiatrist within the last three months.",100.0
665,"Exclusion criteria were: poor English language skills or cognitive function (score of less than 24 on Mini Mental State Examination [20]); BDI score of at least 29 on two consecutive occasions; active suicidal ideas; current or life-time diagnosis of psychosis, organic mental disorder or substance dependency; Kurtzke Expanded Disability Status Scale (EDSS) score of 8.5 or above [21]).",fulltext,"Exclusion criteria were: poor English language skills or cognitive function (score of less than 24 on Mini Mental State Examination [20]); BDI score of at least 29 on two consecutive occasions; active suicidal ideas; current or life-time diagnosis of psychosis, organic mental disorder or substance dependency; Kurtzke Expanded Disability Status Scale (EDSS) score of 8.5 or above [21]).",100.0
665,"At Sheffield potential participants were identified from clinic attenders, MS nurse patient visits and from patients with MS from the caseload of the neuropsychologist. At the Walton Centre potential participants were identified solely from the MS register.",fulltext,"At Sheffield potential participants were identified from clinic attenders, MS nurse patient visits and from patients with MS from the caseload of the neuropsychologist. At the Walton Centre potential participants were identified solely from the MS register.",100.0
665,"The study was conducted at two UK centres - Sheffield Teaching Hospitals NHS Foundation Trust and The Walton Centre NHS Foundation Trust, Liverpool.",fulltext," (Sheffield Teaching Hospitals NHS Trust). We reached our recruitment target on 30 July 2009 (in 281 days; 2.6 participants/month) after adding a second centre (The Walton Centre NHS Foundation Trust, Liverpool)",68.91891891891892
665,The CCBT service provided to trial participants was the routine service provided to all patients referred to the PCT mental health care teams.,fulltext,The CCBT service provided to trial participants was the routine service provided to all patients referred to the PCT mental health care teams.,100.0
665,Only one out of the five participating PCTs around the Sheffield centre formally provided any kind of community facility for accessing CCBT; PCT staff warned that clients rarely used the facility and it was closed during the course of the study.,fulltext,Only one out of the five participating PCTs around the Sheffield centre formally provided any kind of community facility for accessing CCBT; PCT staff warned that clients rarely used the facility and it was closed during the course of the study.,100.0
665,No PCT with whom we worked offered advice or support for defining problems on which to work or applying the CBT model to individual problems.,fulltext,No PCT with whom we worked offered advice or support for defining problems on which to work or applying the CBT model to individual problems.,100.0
665,"The advice given was essentially technical, focusing on using the software.",fulltext,"The advice given was essentially technical, focusing on using the software.",100.0
665,The PCTs delivering CCBT reported that they assumed that patients who were non-adherent and non-contactable beyond two weeks had discontinued treatment and made no further effort to contact them.,fulltext,The PCTs delivering CCBT reported that they assumed that patients who were non-adherent and non-contactable beyond two weeks had discontinued treatment and made no further effort to contact them.,100.0
665,"Identification of prognostic variables, particularly the EDSS and MS Type, from patient records was not always possible and had to be obtained directly from participants' neurologists for the purposes of the study in some cases.",fulltext,"Identification of prognostic variables, particularly the EDSS and MS Type, from patient records was not always possible and had to be obtained directly from participants' neurologists for the purposes of the study in some cases.",100.0
665,"Data collection by postal questionnaire was challenging, with multiple attempts to obtain data from many participants, particularly at later outcome assessment points.",fulltext," collection of outcome data by postal questionnaire proved to be challenging, with multiple attempts to obtain data from many participants, particularly at later outcome assessment points.",95.80838323353294
665,The primary clinical endpoint was the mean change in self-reported symptoms of depression as measured on the BDI.,fulltext,The primary clinical endpoint was the mean change in self-reported symptoms of depression as measured on the BDI.,100.0
665,Participants found problems with the face validity of the depression inventories which include somatic symptoms of depression which are also symptoms of MS.,fulltext,Participants found problems with the face validity of the depression inventories which include somatic symptoms of depression which are also symptoms of MS.,100.0
665,"Primary analysis was an Intention To Treat (ITT) analysis which analysed all 24 participants according to their randomised treatment assignment ignoring non compliance, protocol deviations and withdrawal.",fulltext,"Primary analysis was an Intention To Treat (ITT) analysis which analysed all 24 participants according to their randomised treatment assignment ignoring non compliance, protocol deviations and withdrawal.",100.0
666,"Key inclusion criteria permitted the participation of men or women ≥18 years of age with confirmed and documented RRMS diagnosis (as defined by the Revised McDonald criteria) (Polman et al., 2011), Kurtzke Expanded Disability Status Scale (EDSS) score of 0 to 5.5 at the screening visit, and, 30 days prior to randomization, a stable neurological condition, relapse-free status, and no use of any corticosteroid or adrenocorticotropic hormone treatment.",fulltext,"Key inclusion criteria permitted the participation of men or women ≥18 years of age with confirmed and documented RRMS diagnosis (as defined by the Revised McDonald criteria) (Polman et al., 2011), Kurtzke Expanded Disability Status Scale (EDSS) score of 0 to 5.5 at the screening visit, and, 30 days prior to randomization, a stable neurological condition, relapse-free status, and no use of any corticosteroid or adrenocorticotropic hormone treatment.",100.0
666,"Key exclusion criteria were previous exposure to GA40, a progressive form of MS or neuromyelitis optica, the use of experimental or investigational drugs, participation in clinical drug studies within the 6 months before screening, recent use of immunosuppressive medications or immunoglobulins/monoclonal antibodies, or previous use of alemtuzumab, cladribine, cyclophosphamide, or mitoxantrone.",fulltext,"Key exclusion criteria were previous exposure to GA40, a progressive form of MS or neuromyelitis optica, the use of experimental or investigational drugs, participation in clinical drug studies within the 6 months before screening, recent use of immunosuppressive medications or immunoglobulins/monoclonal antibodies, or previous use of alemtuzumab, cladribine, cyclophosphamide, or mitoxantrone.",100.0
666,This trial was registered with ClinicalTrials.gov (NCT02499900).,fulltext,This trial was registered with ClinicalTrials.gov (NCT02499900).,100.0
666,The study protocol was approved by Independent Ethics Committees or Institutional Review Boards according to national or local regulations.,fulltext,The study protocol was approved by Independent Ethics Committees or Institutional Review Boards according to national or local regulations.,100.0
666,"Patients in the study received treatment for 6 months, and the study was conducted during a period starting in August 2015 and ending in January 2017.",fulltext,"Patients in the study received treatment for 6 months, and the study was conducted during a period starting in August 2015 and ending in January 2017.",100.0
666,"Five scheduled visits at study sites occurred at screening (within 2 weeks prior to baseline), baseline (Month 0), and Months 1, 3, and 6 (end of the core phase).",fulltext,"Five scheduled visits at study sites occurred at screening (within 2 weeks prior to baseline), baseline (Month 0), and Months 1, 3, and 6 (end of the core phase).",100.0
666,"The overall treatment-emergent adverse event (TEAE) profile in both treatment groups was consistent with previous findings (Wolinsky et al., 2015) (Table 2).",fulltext,"The overall treatment-emergent adverse event (TEAE) profile in both treatment groups was consistent with previous findings (Wolinsky et al., 2015) (Table 2).",100.0
666,"All endpoints were compared between the GA40 and GA20 treatment groups during the 6-month treatment period. Patient-reported endpoints used self-reported questionnaires, whereas safety endpoints were assessed by the physicians. The primary endpoint was patient overall satisfaction with the medication as measured by the single-item MSQ 7-point scale (1 = extremely dissatisfied to 7 = extremely satisfied) (Canuso et al., 2010).",fulltext,"All endpoints were compared between the GA40 and GA20 treatment groups during the 6-month treatment period. Patient-reported endpoints used self-reported questionnaires, whereas safety endpoints were assessed by the physicians. The primary endpoint was patient overall satisfaction with the medication as measured by the single-item MSQ 7-point scale (1 = extremely dissatisfied to 7 = extremely satisfied) (Canuso et al., 2010).",100.0
668,"To be included, people had to be aged 18 years or more, have a confirmed diagnosis of relapsing–remitting MS, have an Ambulation Index score19 of 2, 3 or 4 (mild to moderate walking disabilities), and have received medical clearance to participate.",fulltext,"To be included, people had to be aged 18 years or more, have a confirmed diagnosis of relapsing–remitting MS, have an Ambulation Index score19 of 2, 3 or 4 (mild to moderate walking disabilities), and have received medical clearance to participate.",100.0
668,"Volunteers were excluded if they had an acute exacerbation of MS within 2 months of starting the program, had benign or progressive/relapsing types of MS, had a serious unstable medical condition, had any concurrent condition, for example stroke, or had participated in a PRT program in the 6 months before training started.",fulltext,"Volunteers were excluded if they had an acute exacerbation of MS within 2 months of starting the program, had benign or progressive/relapsing types of MS, had a serious unstable medical condition, had any concurrent condition, for example stroke, or had participated in a PRT program in the 6 months before training started.",100.0
668,"Participants were recruited through a statewide organization providing education and support to people with MS, and a large specialist MS outpatient clinic.",fulltext,"Participants were recruited through a statewide organization providing education and support to people with MS, and a large specialist MS outpatient clinic.",100.0
668,"Recruitment information flyers were sent by mail to all potential participants registered on the mailing lists of both organizations. If interested, volunteers were asked to contact one of the researchers (KD) by telephone, during which volunteers were screened to ensure they satisfied the inclusion criteria.",fulltext,"Recruitment information flyers were sent by mail to all potential participants registered on the mailing lists of both organizations. If interested, volunteers were asked to contact one of the researchers (KD) by telephone, during which volunteers were screened to ensure they satisfied the inclusion criteria.",100.0
668,"The experimental group completed a 10-week (two times per week), PRT program in one of four community gymnasiums in metropolitan and regional areas.",fulltext,"The experimental group completed a 10-week (two times per week), PRT program in one of four community gymnasiums in metropolitan and regional areas.",100.0
668,"Each program was attended by a group of up to 12 participants, and they were supervised by up to three experienced trainers (physiotherapists and registered personal sports trainers). Each trainer directly supervised a sub-group of three or four participants.",fulltext,"Each program was attended by a group of up to 12 participants, and they were supervised by up to three experienced trainers (physiotherapists and registered personal sports trainers). Each trainer directly supervised a sub-group of three or four participants.",100.0
668,"The training also took the form of small group-based training; this is important because it made exercising a more social activity, and it was more cost effective and time efficient than individual training.",fulltext,"The training also took the form of small group-based training; this is important because it made exercising a more social activity, and it was more cost effective and time efficient than individual training.",100.0
668,"While these were the core exercises, they could be individualized. For example, if any exercise caused discomfort, the starting position was modified or the exercise was replaced.",fulltext,"While these were the core exercises, they could be individualized. For example, if any exercise caused discomfort, the starting position was modified or the exercise was replaced.",100.0
668,"Outcome measurements were taken three times: at baseline, after 10 weeks to determine the immediate effects of the intervention, and after a further 12 weeks (week 22) to determine if any benefits from the program had been sustained.",fulltext,"Outcome measurements were taken three times: at baseline, after 10 weeks to determine the immediate effects of the intervention, and after a further 12 weeks (week 22) to determine if any benefits from the program had been sustained.",100.0
668,"Outcome measures were taken by a registered physiotherapist blinded to group allocation, and experienced in musculoskeletal evaluation.",fulltext,"Outcome measures were taken by a registered physiotherapist blinded to group allocation, and experienced in musculoskeletal evaluation.",100.0
668,Changes in walking endurance were measured with the 2-minute walk test (2MWT),fulltext,Changes in walking endurance were measured with the 2-minute walk test (2MWT),100.0
668,Changes in maximal walking speed were measured by recording the time taken to walk the middle 10 m of a level 14-m walkway using a stopwatch,fulltext,Changes in maximal walking speed were measured by recording the time taken to walk the middle 10 m of a level 14-m walkway using a stopwatch,100.0
668,"Intention-to-treat analysis was applied, with all participants who were allocated and commenced their program included in analysis. Where data were missing, the carry forward technique was used.",fulltext,"Intention-to-treat analysis was applied, with all participants who were allocated and commenced their program included in analysis. Where data were missing, the carry forward technique was used.",100.0
669,Adults diagnosed with MS were included based on the ability to walk 5 km without rest or use of assistive device.,fulltext,Adults diagnosed with MS were included based on the ability to walk 5 km without rest or use of assistive device.,100.0
669,"Adults with MS were recruited through announcements at REVAL rehabilitation research institute (UHasselt), Flemish MS rehabilitation centers and MS Society, and Move-to-Sport.",fulltext,"Adults with MS were recruited through announcements at REVAL rehabilitation research institute (UHasselt), Flemish MS rehabilitation centers and MS Society, and Move-to-Sport.",100.0
669,"Evaluation was performed at REVAL by a study nurse, a PhD student in Rehabilitation Sciences and Physiotherapy, and the project dedicated researcher (MSc in exercise physiology, PhD).",fulltext,"Evaluation was performed at REVAL by a study nurse, a PhD student in Rehabilitation Sciences and Physiotherapy, and the project dedicated researcher (MSc in exercise physiology, PhD).",100.0
669,pwMS received training instructions by email. They were asked to train three times weekly according to a personalized training intensity schedule that was based on their baseline aerobic capacity.,fulltext,pwMS received training instructions by email. They were asked to train three times weekly according to a personalized training intensity schedule that was based on their baseline aerobic capacity.,100.0
669,pwMS wore an activity tracker (Withings Pulse Ox) at the waist that registered the intensity of steps per minute. Participants were asked to weekly upload data to allow remote supervision of the training adherence by the research assistant.,fulltext,pwMS wore an activity tracker (Withings Pulse Ox) at the waist that registered the intensity of steps per minute. Participants were asked to weekly upload data to allow remote supervision of the training adherence by the research assistant.,100.0
669,"If a participant had been inactive, a phone call was made for enquiry.",fulltext,"If a participant had been inactive, a phone call was made for enquiry.",100.0
669,Participants were tested at two time points (0 and 12 weeks). The EXP group completed a 12-week gradual “start-to-run” program in between time points.,fulltext,Patients were tested at two time points (0 and 12 weeks). The EXP group completed a 12-week gradual “start-to-run” program in between time points.,96.66666666666667
669,"The primary outcome measures were physical fitness, walking capacity and perceived ability, functional mobility, and quality of life.",fulltext,"The primary outcome measures were physical fitness, walking capacity and perceived ability, functional mobility, and quality of life.",100.0
669,Intention-to-treat analysis was performed.,fulltext,Intention-to-treat analysis was performed.,100.0
670,"The inclusion criterion for the study was a diagnosis of multiple sclerosis, and therefore the spectrum of clinical presentations was broad, as would be expected in this client population.",fulltext,"The inclusion criterion for the study was a diagnosis of multiple sclerosis, and therefore the spectrum of clinical presentations was broad, as would be expected in this client population.",100.0
670,"Clients were provided with information about the clinic by the local chapter of the Multiple Sclerosis Society, and self selected on that basis. Of the fifteen study participants, all had previously received a diagnosis of multiple sclerosis.",fulltext,"Clients were provided with information about the clinic by the local chapter of the Multiple Sclerosis Society, and self selected on that basis. Of the fifteen study participants, all had previously received a diagnosis of multiple sclerosis.",100.0
670,"Clients attending the clinic were interviewed, and their case histories recorded. The research project was explained, and written informed consent was obtained.",fulltext,"Clients attending the clinic were interviewed, and their case histories recorded. The research project was explained, and written informed consent was obtained.",100.0
670,"An appropriate history and physical examination was performed, and a treatment plan determined, this being reflective of the therapist's assessment and the mutually set goals for the treatment series.",fulltext,"An appropriate history and physical examination was performed, and a treatment plan determined, this being reflective of the therapist's assessment and the mutually set goals for the treatment series.",100.0
670,"All treatment plans were approved by the clinical teacher in charge. The teacher also monitored treatment delivery, which involved the application of a variety of techniques appropriate to the client's needs.",fulltext,"All treatment plans were approved by the clinical teacher in charge. The teacher also monitored treatment delivery, which involved the application of a variety of techniques appropriate to the client's needs.",100.0
670,"The heterogeneity of the client/participant population precluded an overly prescriptive approach to treatment, and it is worth noting that this heterogeneity is also a component of the normal clinical reality of therapists involved with multiple sclerosis clients.",fulltext,"The heterogeneity of the client/participant population precluded an overly prescriptive approach to treatment, and it is worth noting that this heterogeneity is also a component of the normal clinical reality of therapists involved with multiple sclerosis clients.",100.0
670,"The teacher also monitored treatment delivery, which involved the application of a variety of techniques appropriate to the client's needs.",fulltext,"The teacher also monitored treatment delivery, which involved the application of a variety of techniques appropriate to the client's needs.",100.0
670,"Self-Efficacy scores were obtained before the first treatment, mid-treatment series, after the last treatment in the series, four weeks after the final treatment and again eight weeks after the final treatment had been received.",fulltext,"Self-Efficacy scores were obtained before the first treatment, mid-treatment series, after the last treatment in the series, four weeks after the final treatment and again eight weeks after the final treatment had been received.",100.0
670,The outcome measures for the current research were the scores yielded by the Multiple Sclerosis Self Efficacy (MSSE) survey.,fulltext,The outcome measures for the current research were the scores yielded by the Multiple Sclerosis Self Efficacy (MSSE) survey.,100.0
670,"The data were analyzed on an intention to treat basis, with a focus on the differences between mean MSSE values of the control and intervention groups.",fulltext,"The data were analyzed on an intention to treat basis, with a focus on the differences between mean MSSE values of the control and intervention groups.",100.0
671,"Key inclusion criteria were age older than 18 years, a diagnosis of progressive multiple sclerosis (primary or secondary) according to McDonald's criteria,21 and a score of 6·5–8·0 on the Expanded Disability Status Scale (EDSS).",fulltext,"Key inclusion criteria were age older than 18 years, a diagnosis of progressive multiple sclerosis (primary or secondary) according to McDonald's criteria,21 and a score of 6·5–8·0 on the Expanded Disability Status Scale (EDSS).",100.0
671,"Key exclusion criteria were being within 3 months of ceasing a multiple sclerosis disease-modifying drug, receiving steroid treatment within the preceding month, or participating in another clinical trial.",fulltext,"Key exclusion criteria were being within 3 months of ceasing a multiple sclerosis disease-modifying drug, receiving steroid treatment within the preceding month, or participating in another clinical trial.",100.0
671,"Participants were recruited through eight health-care organisations, including the UK National Health Service (NHS) Trusts, social enterprises, and third sector multiple sclerosis therapy centres, in two regions (Devon–Cornwall and East Anglia) of the UK.",fulltext,"Participants were recruited through eight health-care organisations, including the UK National Health Service (NHS) Trusts, social enterprises, and third sector multiple sclerosis therapy centres, in two regions (Devon–Cornwall and East Anglia) of the UK.",100.0
671,Individuals were invited consecutively until the allocated number of standing frames (dependent on commissioning costs) at each health-care organisation had been reached.,fulltext,Individuals were invited consecutively until the allocated number of standing frames (dependent on commissioning costs) at each health-care organisation had been reached.,100.0
671,"The intervention consisted of two home-based physiotherapy sessions (60 min each) to set up the standing frame programme, supported by six follow-up telephone calls (15 min per call).",fulltext,"The intervention consisted of two home-based physiotherapy sessions (60 min each) to set up the standing frame programme, supported by six follow-up telephone calls (15 min per call).",100.0
671,"Participants were asked to stand for 30 min, three times per week over 20 weeks, and encouraged to continue in the longer term, although no further physiotherapy support was provided.",fulltext,"Participants were asked to stand for 30 min, three times per week over 20 weeks, and encouraged to continue in the longer term, although no further physiotherapy support was provided.",100.0
671,"The use of standing frames is a recognised core skill for UK-trained neurological physiotherapists. To standardise and optimise implementation of the intervention, we provided educational materials and assessed fidelity to them.16 All participants received their usual health and social service input throughout the study period.16 This input was recorded on a self-report health-care and social-care resource form, which included changes in medication.",fulltext,"The use of standing frames is a recognised core skill for UK-trained neurological physiotherapists. To standardise and optimise implementation of the intervention, we provided educational materials and assessed fidelity to them.16 All participants received their usual health and social service input throughout the study period.16 This input was recorded on a self-report health-care and social-care resource form, which included changes in medication.",100.0
671,"In line with previous research,14 participants were asked to stand in the frame for 30 min three times per week over 20 weeks, and to record the frequency and duration of each stand in a daily diary.",fulltext,"In line with previous research,14 participants were asked to stand in the frame for 30 min three times per week over 20 weeks, and to record the frequency and duration of each stand in a daily diary.",100.0
671,This allowed for a graduated introduction to standing.,fulltext,This allowed for a graduated introduction to standing.,100.0
671,"At the end of the 20-week period, participants were encouraged to continue to regularly stand, although no further physiotherapy support was provided.",fulltext,"At the end of the 20-week period, participants were encouraged to continue to regularly stand, although no further physiotherapy support was provided.",100.0
671,"The SUMS study was an individually randomised, controlled, pragmatic, multi-centre, superiority trial with masked outcome assessments in people with progressive multiple sclerosis. Participants were randomly assigned to receive either usual care or usual care plus a standing programme, with masked assessments done at baseline, 20 weeks post-randomisation (aligned with the end of the protocol intervention period for those allocated to the intervention group), and again 16 weeks afterwards (36 weeks post-randomisation).",fulltext,"The SUMS study was an individually randomised, controlled, pragmatic, multi-centre, superiority trial with masked outcome assessments in people with progressive multiple sclerosis. Participants were randomly assigned to receive either usual care or usual care plus a standing programme, with masked assessments done at baseline, 20 weeks post-randomisation (aligned with the end of the protocol intervention period for those allocated to the intervention group), and again 16 weeks afterwards (36 weeks post-randomisation).",100.0
671,"We achieved this by using daily, self-reported, preformatted diaries.",fulltext,"We achieved this by using daily, self-reported, preformatted diaries.",100.0
671,"The primary outcome was motor function as measured by the Amended Motor Club Assessment (AMCA) score23 at the primary endpoint of 36 weeks post-randomisation. This score was developed for use by physiotherapists in a clinical setting to assess motor function in people with multiple sclerosis and has shown validity, reliability, and responsiveness.",fulltext,"The primary outcome was motor function as measured by the Amended Motor Club Assessment (AMCA) score23 at the primary endpoint of 36 weeks post-randomisation. This score was developed for use by physiotherapists in a clinical setting to assess motor function in people with multiple sclerosis and has shown validity, reliability, and responsiveness.",100.0
671,"The primary analysis of the primary outcome, AMCA score at 36 weeks, followed a modified intention-to-treat approach, regardless of compliance to the intervention, but did exclude patients who were deemed ineligible after randomisation, those who withdrew from the trial and were unwilling for their previously collected data to be used, or those who did not provide baseline and week 36 measurements (ie, there was no imputation of missing baseline or week 36 scores for the primary analysis), and used an analysis of covariance (ANCOVA) approach.",fulltext,"The primary analysis of the primary outcome, AMCA score at 36 weeks, followed a modified intention-to-treat approach, regardless of compliance to the intervention, but did exclude patients who were deemed ineligible after randomisation, those who withdrew from the trial and were unwilling for their previously collected data to be used, or those who did not provide baseline and week 36 measurements (ie, there was no imputation of missing baseline or week 36 scores for the primary analysis), and used an analysis of covariance (ANCOVA) approach.",100.0
673,"Eligible participants were over 18 years of age and had a diagnosis of MS that was confirmed by a consultant physician or neurologist. Persons with MS were excluded if they had a previous relapse or began steroid therapy in the 12 weeks prior to participating in the first assessment, were pregnant, or had a comorbidity that severely impacted their ability to safely participate in exercise.",fulltext,"Eligible participants were over 18 years of age and had a diagnosis of MS that was confirmed by a consultant physician or neurologist. Persons with MS were excluded if they had a previous relapse or began steroid therapy in the 12 weeks prior to participating in the first assessment, were pregnant, or had a comorbidity that severely impacted their ability to safely participate in exercise.",100.0
673,"Participants were enrolled following their eligibility assessments, performed by the regional offices of MSI. Once consent for eight people of a strand in a specific geographical area was obtained, the regional office of MSI contacted the national coordinator (AL) who allocated that block of participants to the control or an intervention.",fulltext,"Participants were enrolled following their eligibility assessments, performed by the regional offices of MSI. Once consent for eight people of a strand in a specific geographical area was obtained, the regional office of MSI contacted the national coordinator (AL) who allocated that block of participants to the control or an intervention.",100.0
673,"Our study participants were referred to the project by themselves, their care-giver, MSI, chartered physiotherapists, neurologists, general practitioners or clinical nurse specialists.",fulltext,"Our study participants were referred to the project by themselves, their care-giver, MSI, chartered physiotherapists, neurologists, general practitioners or clinical nurse specialists.",100.0
673,"All interventions took place in groups of eight, for an hour per week, for 10 weeks. They were delivered in community centres such as local gyms, hotels and health centres.",fulltext,"All interventions took place in groups of eight, for an hour per week, for 10 weeks. They were delivered in community centres such as local gyms, hotels and health centres.",100.0
673,"In the PT-led programme, there was a home exercise component consisting of 10 aerobic sessions to be performed during weeks 1 – 5 (i.e. resulting in a frequency of two per week).",fulltext,"In the PT-led programme, there was a home exercise component consisting of 10 aerobic sessions to be performed during weeks 1 – 5 (i.e. resulting in a frequency of two per week).",100.0
673,The PT-led exercise provided was pre-defined. It consisted of a circuit-style class of exercises that were either resisted by body weight or by the addition of free weights.,fulltext,The PT-led exercise provided was pre-defined. It consisted of a circuit-style class of exercises that were either resisted by body weight or by the addition of free weights.,100.0
673,Treatment fidelity was optimised by the instructors and participants documenting programme adherence.,fulltext,Treatment fidelity was optimised by the instructors and participants documenting programme adherence.,100.0
673,"The primary outcome measure was the physical component of the Multiple Sclerosis Impact Scale- 29, version 2 (MSIS-29v2), a patient-reported outcome measure that assesses the physical impact of MS.",fulltext,"The primary outcome measure was the physical component of the Multiple Sclerosis Impact Scale- 29, version 2 (MSIS-29v2), a patient-reported outcome measure that assesses the physical impact of MS.",100.0
673,All participants were analysed in the groups to which they were randomised.,fulltext,All participants were analysed in the groups to which they were randomised.,100.0
674,"Comparison of Alemtuzumab and Rebif Efficacy in Multiple Sclerosis (CARE-MS) II, a 2-year randomized, rater-blinded, active-controlled, head-to-head, phase 3 trial, compared efficacy and safety of alemtuzumab 12 mg with subcutaneous interferon-β-1a (SC IFN-β-1a) 44 μg in patients with RRMS.",fulltext,"Comparison of Alemtuzumab and Rebif Efficacy in Multiple Sclerosis (CARE-MS) II, a 2-year randomized, rater-blinded, active-controlled, head-to-head, phase 3 trial, compared efficacy and safety of alemtuzumab 12 mg with subcutaneous interferon-β-1a (SC IFN-β-1a) 44 μg in patients with RRMS.",100.0
674,"CARE-MS II was a 2-year, randomized, rater-blinded, active comparator-controlled, head-to-head, trial of alemtuzumab (Lemtrada; Sanofi Genzyme, Cambridge, MA; 12 mg/day on 5 consecutive days at month 0 and on 3 consecutive days at month 12) vs SC IFN-β-1a (Rebif; EMD Serono, Rockland, MA; 44 μg 3 times weekly) in patients with RRMS with inadequate response to prior DMTs (≥1 relapse during IFN-β or glatiramer acetate [GA] treatment [received for ≥6 months]).",fulltext,"CARE-MS II was a 2-year, randomized, rater-blinded, active comparator-controlled, head-to-head, trial of alemtuzumab (Lemtrada; Sanofi Genzyme, Cambridge, MA; 12 mg/day on 5 consecutive days at month 0 and on 3 consecutive days at month 12) vs SC IFN-β-1a (Rebif; EMD Serono, Rockland, MA; 44 μg 3 times weekly) in patients with RRMS with inadequate response to prior DMTs (≥1 relapse during IFN-β or glatiramer acetate [GA] treatment [received for ≥6 months]).",100.0
674,"Blinded raters performed EDSS assessments at baseline, every 3 months, and when relapse was suspected.",fulltext,"Blinded raters performed EDSS assessments at baseline, every 3 months, and when relapse was suspected.",100.0
674,"Raters administered the MSFC16 3 times before baseline to attenuate practice effects, then every 6 months.",fulltext,"Raters administered the MSFC16 3 times before baseline to attenuate practice effects, then every 6 months.",100.0
674,"Among MSFC components (figure 3, B–D), the greater benefit seen at month 24 with alemtuzumab vs SC IFN-β-1a reached statistical significance for the 9-HPT (p = 0.0007).",fulltext,"Among MSFC components (figure 3, B–D), the greater benefit seen at month 24 with alemtuzumab vs SC IFN-β-1a reached statistical significance for the 9-HPT (p = 0.0007).",100.0
675,"Neurologists verified all patients for the following inclusion criteria: 1) diagnosis of relapsing-remitting (but no more than 2 exacerbations within the last year) or secondary progressive MS21 and 2) an Expanded Disability Status Scale (EDSS)22 score of ≤6 (no to moderately severe disability), with ≤1 step increase within the last year.",fulltext,"Neurologists verified all patients for the following inclusion criteria: 1) diagnosis of relapsing-remitting (but no more than 2 exacerbations within the last year) or secondary progressive MS21 and 2) an Expanded Disability Status Scale (EDSS)22 score of ≤6 (no to moderately severe disability), with ≤1 step increase within the last year.",100.0
675,"Excluded were patients with reported or medically recorded diagnoses of current serious psychological disorders other than depression and anxiety syndromes, evidence of dementia as indicated by testing below the fifth percentile in at least 3 of 6 dimensions of neuropsychological functioning (i.e., attention and concentration, processing speed, executive function, verbal memory, and verbal processing), other currently life-threatening or severely disabling physical disorders, current MS exacerbation, symptomatic MS medication altered in the last 3 months, other disorders of the CNS, pregnancy, or inability to speak or read German.",fulltext,"Excluded were patients with reported or medically recorded diagnoses of current serious psychological disorders other than depression and anxiety syndromes, evidence of dementia as indicated by testing below the fifth percentile in at least 3 of 6 dimensions of neuropsychological functioning (i.e., attention and concentration, processing speed, executive function, verbal memory, and verbal processing), other currently life-threatening or severely disabling physical disorders, current MS exacerbation, symptomatic MS medication altered in the last 3 months, other disorders of the CNS, pregnancy, or inability to speak or read German.",100.0
675,A total of 164 patients self-referred to the study.,fulltext,A total of 164 patients self-referred to the study.,100.0
675,The study was conducted from February 2007 to March 2009.,fulltext,The study was conducted from February 2007 to March 2009.,100.0
675,"MBI closely followed the program of mindfulness-based stress reduction23 and included 1) a personal intake interview to define realistic goals of participants and establish personal rapport; 2) 8 weekly 2.5-hour classes in mindfulness practices (10–15 participants/group; exercises did not exceed patients' level of functioning); 3) one Saturday, 7-hour session at week 6; 4) homework assignments (approximately 40 minutes/day), emphasized as essential to success of the program; 5) a postintervention interview to evaluate personal experiences, goal attainment, and future maintenance of acquired skills.",fulltext,"MBI closely followed the program of mindfulness-based stress reduction23 and included 1) a personal intake interview to define realistic goals of participants and establish personal rapport; 2) 8 weekly 2.5-hour classes in mindfulness practices (10–15 participants/group; exercises did not exceed patients' level of functioning); 3) one Saturday, 7-hour session at week 6; 4) homework assignments (approximately 40 minutes/day), emphasized as essential to success of the program; 5) a postintervention interview to evaluate personal experiences, goal attainment, and future maintenance of acquired skills.",100.0
675,"MBI closely followed the program of mindfulness-based stress reduction23 and included 1) a personal intake interview to define realistic goals of participants and establish personal rapport; 2) 8 weekly 2.5-hour classes in mindfulness practices (10–15 participants/group; exercises did not exceed patients' level of functioning); 3) one Saturday, 7-hour session at week 6; 4) homework assignments (approximately 40 minutes/day), emphasized as essential to success of the program; 5) a postintervention interview to evaluate personal experiences, goal attainment, and future maintenance of acquired skills.",fulltext,"MBI closely followed the program of mindfulness-based stress reduction23 and included 1) a personal intake interview to define realistic goals of participants and establish personal rapport; 2) 8 weekly 2.5-hour classes in mindfulness practices (10–15 participants/group; exercises did not exceed patients' level of functioning); 3) one Saturday, 7-hour session at week 6; 4) homework assignments (approximately 40 minutes/day), emphasized as essential to success of the program; 5) a postintervention interview to evaluate personal experiences, goal attainment, and future maintenance of acquired skills.",100.0
675,"MBI participants reported practicing, on average, 5.11 times/week (SD 2.24; CI 4.59–5.64 times), a total time average of 76% of assigned homework (SD 13.80; CI 72.76%–79.25%).",fulltext,"MBI participants reported practicing, on average, 5.11 times/week (SD 2.24; CI 4.59–5.64 times), a total time average of 76% of assigned homework (SD 13.80; CI 72.76%–79.25%).",100.0
675,"Assessments were made at baseline, postintervention, and 6 months follow-up.",fulltext,"Assessments were made at baseline, postintervention, and 6 months follow-up.",100.0
675,"Primary outcomes included disease-specific and disease-aspecific HRQOL, depression, and fatigue.",fulltext,"Primary outcomes included disease-specific and disease-aspecific HRQOL, depression, and fatigue.",100.0
675,"Intention-to-treat analyses are reported. Data of missing study patients were imputed by linear multiple regression that adjusted for age, gender, and disease progression (entry EDSS score; STATISTICA 6.0).",fulltext,"Intention-to-treat analyses are reported. Data of missing study patients were imputed by linear multiple regression that adjusted for age, gender, and disease progression (entry EDSS score; STATISTICA 6.0).",100.0
677,"Eighty-one patients with chronic stroke, traumatic brain injury (TBI) and multiple sclerosis (MS) were recruited",fulltext,"Eighty-one patients with chronic stroke, traumatic brain injury (TBI) and multiple sclerosis (MS) were recruited",100.0
677,subjects passed the screening criteria,fulltext,subjects passed the screening criteria,100.0
677,"Exclusions were: A) disturbed upper limb function not related to MS, TBI or stroke; B) serious cognitive and/or behavioral problems; C) serious emotional problems; D) major visual problems; (E) communication problems; F) medical complications; G) other problems possibly contra-indicating autonomous exercise at home.",fulltext,"Exclusions were: A) disturbed upper limb function not related to MS, TBI or stroke; B) serious cognitive and/or behavioral problems; C) serious emotional problems; D) major visual problems; (E) communication problems; F) medical complications; G) other problems possibly contra-indicating autonomous exercise at home.",100.0
677,"The tele-rehabilitation service is mainly addressed to neurological patients affected by traumatic brain injury (TBI), stroke or multiple sclerosis (MS)",fulltext,"The tele-rehabilitation service is mainly addressed to neurological patients affected by traumatic brain injury (TBI), stroke or multiple sclerosis (MS)",100.0
677,"Patients were recruited from Unità Organica di Riabilitazione Intensiva Neuromotoria (UORIN, Italy), Foundation Institute Guttmann (FPING, Spain) and from National Multiple Sclerosis Centre (NMSC, Belgium)",fulltext,"Patients were recruited from Unità Organica di Riabilitazione Intensiva Neuromotoria (UORIN, Italy), Foundation Institute Guttmann (FPING, Spain) and from National Multiple Sclerosis Centre (NMSC, Belgium)",100.0
677,"The actual intervention with the H-CAD system at home consisted of one month, whereby the patients had an average of one training session a day lasting 30 minutes for at least 5 days a week.",fulltext,"The actual intervention with the H-CAD system at home consisted of one month, whereby the patients had an average of one training session a day lasting 30 minutes for at least 5 days a week.",100.0
677,"The following exercises are part of the H-CAD system: key, light bulb, book, jar, writing, checkers and keyboard tasks.",fulltext,"The following exercises are part of the H-CAD system: key, light bulb, book, jar, writing, checkers and keyboard tasks.",100.0
677,All measurements were performed at the centre where the patient had been treated.,fulltext,All measurements were performed at the centre where the patient had been treated.,100.0
677,The second measurement (T1) was performed after the month of usual care (for intervention as well as control group). The third measurement (T2) was performed after the month of H-CAD intervention for the intervention group and 2 months after baseline for the control group. A month after T2 a follow up measurement was performed (T3) for the intervention group. The control group received their last measurement (T3) 4 months after baseline.,fulltext,The second measurement (T1) was performed after the month of usual care (for intervention as well as control group). The third measurement (T2) was performed after the month of H-CAD intervention for the intervention group and 2 months after baseline for the control group. A month after T2 a follow up measurement was performed (T3) for the intervention group. The control group received their last measurement (T3) 4 months after baseline.,100.0
677,"Two outcome parameters representing the performance of the affected arm on functioning as well on disability level were used in the present study as main outcome parameters. In case both arms were affected, the dominant hand was used The main outcome parameters were the ARA test and the NHPT.",fulltext,"Two outcome parameters representing the performance of the affected arm on functioning as well on disability level were used in the present study as main outcome parameters. In case both arms were affected, the dominant hand was used The main outcome parameters were the ARA test and the NHPT.",100.0
677,"The ARA is an observational test consisting of 19 items focusing on grasping objects of different shapes and sizes, and gross movements in the vertical and horizontal planes (score range: 0 to 57)",fulltext,"The ARA is an observational test consisting of 19 items focusing on grasping objects of different shapes and sizes, and gross movements in the vertical and horizontal planes (score range: 0 to 57)",100.0
677,"The NHPT measures manual dexterity (and reaching and grasping). The total time needed to move the 9 pegs with the affected arm was used as outcome parameter. When the patient was unable to move all nine pegs, the total time of 180 seconds was used.",fulltext,"The NHPT measures manual dexterity (and reaching and grasping). The total time needed to move the 9 pegs with the affected arm was used as outcome parameter. When the patient was unable to move all nine pegs, the total time of 180 seconds was used.",100.0
677,A significance level of 0.025 and a confidence interval of 95% were used.,fulltext,A significance level of 0.025 and a confidence interval of 95% were used.,100.0
677,"When the confidence bounds remained between these boundaries, no difference between usual care and H-CAD was found.",fulltext,"When the confidence bounds remained between these boundaries, no difference between usual care and H-CAD was found.",100.0
678,Patients in South East London who were severely affected by MS were referred by clinicians to the trial.,fulltext,Patients in South East London who were severely affected by MS were referred by clinicians to the trial.,100.0
678,"Inclusion criteria were patients in South East London, living with MS and deemed (by clinicians) to have one or more of unresolved symptoms, psychosocial concerns, end-of-life issues, progressive illness, or complex needs (i.e., palliative care needs).",fulltext,"Inclusion criteria were patients in South East London, living with MS and deemed (by clinicians) to have one or more of unresolved symptoms, psychosocial concerns, end-of-life issues, progressive illness, or complex needs (i.e., palliative care needs).",100.0
678,Referrals were screened by a consultant in palliative medicine who was independent from delivering the service (P. M. E./I. J. H).,fulltext,Referrals were screened by a consultant in palliative medicine who was independent from delivering the service (P. M. E./I. J. H).,100.0
678,Educational seminars informed local health and social care professionals about the PCT.,fulltext,Educational seminars informed local health and social care professionals about the PCT.,100.0
678,"Patients were visited in their own homes or sometimes outpatient clinics, nursing homes, or hospital.",fulltext,"Patients were visited in their own homes or sometimes outpatient clinics, nursing homes, or hospital.",100.0
678,"In addition to continuing to receive usual services (see below), patients in the fast-track group received care from a PCT. This comprised one part-time consultant in palliative medicine, one part-time clinical nurse specialist, one administrator, and one psychosocial worker, and was based in a large teaching hospital.",fulltext,"In addition to continuing to receive usual services (see below), patients in the fast-track group received care from a PCT.18, 20 This comprised one part-time consultant in palliative medicine, one part-time clinical nurse specialist, one administrator, and one psychosocial worker, and was based in a large teaching hospital.",100.0
678,"Care was provided in a similar way to palliative care consultation services described elsewhere,9, 11 although the PCT worked in both hospital and the community, and so could visit patients wherever they were. Patients had one to three contacts (visits and/or phone calls) from the PCT...",fulltext,"Care was provided in a similar way to palliative care consultation services described elsewhere,9, 11 although the PCT worked in both hospital and the community, and so could visit patients wherever they were. Patients had one to three contacts (visits and/or phone calls) from the PCT, ",99.65277777777779
678,"We conducted face-to-face interviews with patients and gave self-complete questionnaires to caregivers. At baseline, we collected demographic and clinical data, and the patient's functional status...",fulltext,"We conducted face-to-face interviews with patients and gave self-complete questionnaires to caregivers. At baseline, we collected demographic and clinical data, and the patient's functional status (",99.49748743718592
678,"Our standardized questionnaires included the Palliative Care Outcome Scale (POS-8), comprising eight questions on anxiety, patient and carer concerns, and practical needs, each rated 0–4; a single-item POS pain score (rated 0 [best] to 4 [worst]); and caregivers' burden (using the 12-item version of the Zarit Carer Burden Inventory [ZBI]).",fulltext,"Our standardized questionnaires included the Palliative Care Outcome Scale (POS-8),24, 25 comprising eight questions on anxiety, patient and carer concerns, and practical needs, each rated 0–4; a single-item POS pain score (rated 0 [best] to 4 [worst]); and caregivers' burden (using the 12-item version of the Zarit Carer Burden Inventory [ZBI]).",100.0
678,"We planned an intention-to-treat analysis, irrespective of whether patients were assessed as having palliative care needs or the nature of contact with the PCT.",fulltext,"We planned an intention-to-treat analysis, irrespective of whether patients were assessed as having palliative care needs or the nature of contact with the PCT.",100.0
679,"Eligibility criteria for patients: diagnosis RRMS since at least one year, EDSS score ≤4.0, no symptoms suggestive of a relapse, no relapse in the preceding four weeks, willing and capable of participating in the investigations, and having access to the internet for performing the web-based assessments.",fulltext,"Eligibility criteria for patients: diagnosis RRMS since at least one year, EDSS score ≤4.0, no symptoms suggestive of a relapse, no relapse in the preceding four weeks, willing and capable of participating in the investigations, and having access to the internet for performing the web-based assessments.",100.0
679,"Participants were recruited from all over the Netherlands by the patient organisation NMSF, Rotterdam, the Netherlands. Interested patients were contacted by a registered nurse experienced in MS (MH) by phone to check diagnosis and eligibility criteria.",fulltext,"Participants were recruited from all over the Netherlands by the patient organisation NMSF, Rotterdam, the Netherlands. Interested patients were contacted by a registered nurse experienced in MS (MH) by phone to check diagnosis and eligibility criteria.",100.0
679,"CDTs were given during three consecutive days in Zorghotel Spelderholt, Beekbergen, the Netherlands, a facility especially equipped for the accommodation of people with impaired health.",fulltext,"CDT was given during three consecutive days in Zorghotel Spelderholt, Beekbergen, the Netherlands, a facility especially equipped for the accommodation of people with impaired health.",97.83783783783784
679,"The multidisciplinary team included a psychiatrist, psychiatric nurse, neurologist, registered nurse specialized in MS, physiotherapist, dance therapist, and a person with MS. All professional team members were formally trained in their respective disciplines and all members were experienced in the field of MS.",fulltext,"The multidisciplinary team included a psychiatrist, psychiatric nurse, neurologist, registered nurse specialized in MS, physiotherapist, dance therapist, and a person with MS [9]. All professional team members were formally trained in their respective disciplines and all members were experienced in the field of MS.",100.0
679,During the consultations they [multidisciplinary team members] had a professional and informative role. In the small group sessions every team member focused on its own area of interest.,fulltext,During the consultations they had a professional and informative role. In the small group sessions every team member focused on its own area of interest.,82.25806451612902
679,"Assessments were at baseline and at one, three and six months follow-up via online questionnaires (www.ms4ri.nl).",fulltext,"Assessments were at baseline and at one, three and six months follow-up via online questionnaires (www.ms4ri.nl).",100.0
679,"The primary study outcome was the change in control self-efficacy, assessed by the Multiple Sclerosis Self-Efficacy Scale (MSSES), at six months.",fulltext,"The primary study outcome was the change in control self-efficacy, assessed by the Multiple Sclerosis Self-Efficacy Scale (MSSES), at six months.",100.0
679,"All endpoints were analyzed according to the intention-to-treat principle using an ANCOVA with the 6-month value as dependent variable, and condition, baseline value, disease duration and gender as independent variables.",fulltext,"All endpoints were analyzed according to the intention-to-treat principle using an ANCOVA with the 6-month value as dependent variable, and condition, baseline value, disease duration and gender as independent variables.",100.0
680,Inclusion criteria were: 1) having a definite diagnosis of MS from a neurologist; 2) being within 5 years of receiving a diagnosis of MS; 3) scoring at least 10 on the Beck Depression Inventory-II (BDI-II) [26]; 4) not currently undertaking other psychological treatment for depressive or anxiety symptoms for the length of participation in the current trial; 5) speak English fluently; 6) no current or lifetime diagnosis of psychosis; 7) no current substance dependency; 8) no gross cognitive impairment; and 9) no changes to medications prior and during involvement in the trial.,fulltext,Inclusion criteria were: 1) having a definite diagnosis of MS from a neurologist; 2) being within 5 years of receiving a diagnosis of MS; 3) scoring at least 10 on the Beck Depression Inventory-II (BDI-II) [26]; 4) not currently undertaking other psychological treatment for depressive or anxiety symptoms for the length of participation in the current trial; 5) speak English fluently; 6) no current or lifetime diagnosis of psychosis; 7) no current substance dependency; 8) no gross cognitive impairment; and 9) no changes to medications prior and during involvement in the trial.,100.0
680,"Participants were recruited through neurologists working in a large MS outpatient clinic at the hospital, advertisements on MS related websites and local press releases.",fulltext,"Participants were recruited through neurologists working in a large MS outpatient clinic at the hospital, advertisements on MS related websites and local press releases.",100.0
680,"The study took place at a large teaching and research hospital in Melbourne, Australia.",fulltext,"The study took place at a large teaching and research hospital in Melbourne, Australia.",100.0
680,A senior clinical psychologist and a provisional clinical psychologist (supervised by the clinical psychologist) provided the intervention.,fulltext,A senior clinical psychologist and a provisional clinical psychologist (supervised by the clinical psychologist) provided the intervention.,100.0
680,A senior clinical psychologist and a provisional clinical psychologist (supervised by the clinical psychologist) provided the intervention.,fulltext,A senior clinical psychologist and a provisional clinical psychologist (supervised by the clinical psychologist) provided the intervention.,100.0
680,"The CBT intervention consisted of 8 individual modules which focused on CBT based principles and strategies. These strategies included progressive muscle relaxation, controlled breathing exercises, pleasant activity scheduling, problem solving skills, cognitive exercises which helped individuals identify, challenge and manage unhelpful thoughts and beliefs.",fulltext,"The CBT intervention consisted of 8 individual modules which focused on CBT based principles and strategies. These strategies included progressive muscle relaxation, controlled breathing exercises, pleasant activity scheduling, problem solving skills, cognitive exercises which helped individuals identify, challenge and manage unhelpful thoughts and beliefs.",100.0
680,"All participants in the CBT intervention reported reading and completing all of the materials provided for homework and reported that the intervention was ‘very useful’,",fulltext,"All participants in the CBT intervention reported reading and completing all of the materials provided for homework and reported that the intervention was ‘very useful’,",100.0
680,All participants completed questionnaires at pre- and post-treatment and at 20 weeks follow up.,fulltext,All participants completed questionnaires at pre- and post-treatment and at 20 weeks follow up.,100.0
680,The primary outcome was level of depressive symptoms at post and 3 month follow up which was measured with the Beck Depression Inventory-II (BDI-II),fulltext,The primary outcome was level of depressive symptoms at post and 3 month follow up which was measured with the Beck Depression Inventory-II (BDI-II),100.0
681,"Participants had a confirmed diagnosis of multiple sclerosis, an Extended Disability Status Scale score of 5 (ambulatory without aid or rest for about 200 m) to 6.5 (constant bilateral assistance required to walk about 20 m without resting), stable rehabilitation and drug therapy for 30 days before entry into the study, cognitive scores of over 24 on the Mini-Mental State Examination34 and access to the intervention sites using their own or public transport.",fulltext,"Participants had a confirmed diagnosis of multiple sclerosis, an Extended Disability Status Scale33 score of 5 (ambulatory without aid or rest for about 200 m) to 6.5 (constant bilateral assistance required to walk about 20 m without resting), stable rehabilitation and drug therapy for 30 days before entry into the study, cognitive scores of over 24 on the Mini-Mental State Examination34 and access to the intervention sites using their own or public transport.",100.0
681,"Potential participants were excluded if they had experienced exacerbation of their multiple sclerosis symptoms three months prior to the study, or had any medical condition which may preclude them from taking part in the exercise intervention.",fulltext,"Potential participants were excluded if they had experienced exacerbation of their multiple sclerosis symptoms three months prior to the study, or had any medical condition which may preclude them from taking part in the exercise intervention.",100.0
681,NHS Ayrshire and Arran hold a register of all patients known to the multiple sclerosis service. Participants were recruited from this register.,fulltext,NHS Ayrshire and Arran hold a register of all patients known to the multiple sclerosis service. Participants were recruited from this register.,100.0
681,Of the 873 patients on the clinical register for multiple sclerosis 159 patients were deemed suitable for the study. These people were sent invitation letters and participant information sheets.,fulltext,Of the 873 patients on the clinical register for multiple sclerosis 159 patients were deemed suitable for the study. These people were sent invitation letters and participant information sheets.,100.0
681,"The intervention took place at two different geographical locations (Site A and Site B). From those living near Site A a list of potential participants (n = 16) was created and, to maximise class occupancy, 10 potential participants were allocated to Site A’s intervention group. A similar system was used for Site B (which had a class capacity of 12), for which a list of potential participants (n = 20) was created.",fulltext,"The intervention took place at two different geographical locations (Site A and Site B). From those living near Site A a list of potential participants (n = 16) was created and, to maximise class occupancy, 10 potential participants were allocated to Site A’s intervention group. A computer program (Microsoft Excel 2003) was set up to randomly assign the 10 people to the exercise group and 6 to the control group. A similar system was used for Site B (which had a class capacity of 12), for which a list of potential participants (n = 20) was created.",100.0
681,"This study aimed to evaluate the effectiveness (as defined by an improvement in disease signs and symptoms) of a group, community leisure centre-based combined exercise (aerobic, resistance and balance exercises) intervention for people moderately affected with multiple sclerosis.",fulltext,"This study aimed to evaluate the effectiveness (as defined by an improvement in disease signs and symptoms) of a group, community leisure centre-based combined exercise (aerobic, resistance and balance exercises) intervention for people moderately affected with multiple sclerosis.",100.0
681,Each group was led by two instructors (one physiotherapist and one fitness instructor). The same physiotherapist was present at both sites; however fitness instructors were different between sites.,fulltext,Each group was led by two instructors (one physiotherapist and one fitness instructor). The same physiotherapist was present at both sites; however fitness instructors were different between sites.,100.0
681,"The group session involved a 10-minute warm-up of aerobic and stretching components, 30–40 minutes of circuit exercises (Appendix 1 on-line), designed to train aerobic endurance, resistance and balance, and a 5–10 minute cool-down, involving aerobic work, stretching and relaxation.",fulltext,"The group session involved a 10-minute warm-up of aerobic and stretching components, 30–40 minutes of circuit exercises (Appendix 1 on-line), designed to train aerobic endurance, resistance and balance, and a 5–10 minute cool-down, involving aerobic work, stretching and relaxation.",100.0
681,"Through discussion with the instructors, participants chose which level of each exercise they deemed appropriate and also when and how each exercise should be progressed. Participants worked at a self-regulated pace for each exercise.",fulltext,"Through discussion with the instructors, participants chose which level of each exercise they deemed appropriate and also when and how each exercise should be progressed. Participants worked at a self-regulated pace for each exercise.",100.0
681,"Not all exercises were performed at all classes, and in week 9 a fifth level of difficulty was added to some of the exercises to encourage progress.",fulltext,"Not all exercises were performed at all classes, and in week 9 a fifth level of difficulty was added to some of the exercises to encourage progress.",100.0
681,"Outcome measures were carried out within the local hospital’s rehabilitation unit. They were taken at baseline, after 8 and 12 weeks of the intervention period (i.e. either the exercise class or usual care).",fulltext,"Outcome measures were carried out within the local hospital’s rehabilitation unit. They were taken at baseline, after 8 and 12 weeks of the intervention period (i.e. either the exercise class or usual care).",100.0
681,"To counteract the potential effects of fatigue, three versions of the assessment protocol were used, with tests carried out in different orders. The version used was randomly allocated at baseline to each participant, with the same version of assessment subsequently used at weeks 8 and 12.",fulltext,"To counteract the potential effects of fatigue, three versions of the assessment protocol were used, with tests carried out in different orders. The version used was randomly allocated at baseline to each participant, with the same version of assessment subsequently used at weeks 8 and 12.",100.0
681,The Timed 25-Foot Walk Test35 was chosen as the primary outcome measure. The Timed 25-Foot Walk Test measures walking speed over a short distance and has shown good reliability and validity in the multiple sclerosis population as an individual component of the Multiple Sclerosis Functional Composite disability assessment.,fulltext,The Timed 25-Foot Walk Test35 was chosen as the primary outcome measure. The Timed 25-Foot Walk Test measures walking speed over a short distance and has shown good reliability and validity in the multiple sclerosis population as an individual component of the Multiple Sclerosis Functional Composite disability assessment.,100.0
682,Ambulatory and sedentary.,fulltext,Ambulatory and sedentary.,100.0
682,Excluded were people who were (1) unable to speak and read English or French; (2) unable to respond to simple questions on orientation and memory; (3) have an additional illness that restricts their function; and/or (4) experienced a relapse during the past 30 days as this may affect physical activity/exercise participation.,fulltext,Excluded were people who were (1) unable to speak and read English or French; (2) unable to respond to simple questions on orientation and memory; (3) have an additional illness that restricts their function; and/or (4) experienced a relapse during the past 30 days as this may affect physical activity/exercise participation.,100.0
682,People were recruited from four multiple sclerosis clinics in three Canadian cities and from posting on media sites.,fulltext,People were recruited from four multiple sclerosis clinics in three Canadian cities and from posting on media sites.,100.0
682,"During the clinic visit, the treating neurologist introduced the study to their patients and referred them to the research assistant who further explained the study and assessed eligibility.",fulltext,"During the clinic visit, the treating neurologist introduced the study to their patients and referred them to the research assistant who further explained the study and assessed eligibility.",100.0
682,"All participants were contacted every two weeks during the first two months, then monthly thereafter by the exercise instructor by telephone or email for follow-up.",fulltext,"All participants were contacted every two weeks during the first two months, then monthly thereafter by the exercise instructor by telephone or email for follow-up.",100.0
682,The purpose of follow-up contacts is to provide an opportunity to ask any questions they have and also to facilitate long-term retention in the study.,fulltext,The purpose of follow-up contacts is to provide an opportunity to ask any questions they have and also to facilitate long-term retention in the study.,100.0
682,"MSTEP©, a personally adapted exercise regimen including a variety of exercises targeting endurance, muscular, and core strength, balance, flexibility, muscular power, and speed of movement.",fulltext,"MSTEP©, a personally adapted exercise regimen including a variety of exercises targeting endurance, muscular, and core strength, balance, flexibility, muscular power, and speed of movement.",100.0
682,"All had their exercise regimens reviewed during the intervention year at the evaluations which were scheduled at 3, 6, and 12 months.",fulltext,"All had their exercise regimens reviewed during the intervention year at the evaluations which were scheduled at 3, 6, and 12 months.",100.0
682,Evaluators were blinded to the group that the participant was in.,fulltext,Evaluators were blinded to the group that the participant was in.,100.0
682,"As there were four visits during the first year with four opportunities for missing data, the first set of analyses addressed whether the pattern of missing data was associated with the outcomes measured in this study.",fulltext,"As there were four visits during the first year with four opportunities for missing data, the first set of analyses addressed whether the pattern of missing data was associated with the outcomes measured in this study.",100.0
682,Primary outcome was peak oxygen consumption (VO2peak) at 12 months,fulltext,Primary outcome was peak oxygen consumption (VO2peak) at 12 months,100.0
682,"The planned sample size was 240, 120 per group, based on 80% power, significance level of 0.05, and a hypothesized 20% response in the Guideline group and a 50% response in the MSTEP© group.",fulltext,"The planned sample size was 240, 120 per group, based on 80% power, significance level of 0.05, and a hypothesized 20% response in the Guideline group and a 50% response in the MSTEP© group.",100.0
684,"People moderately to severely affected by MS (Extended Disability Status Score, EDSS, 6.5–8) were randomized to an intervention or control group.",fulltext,"People moderately to severely affected by MS (Extended Disability Status Score, EDSS, 6.5–8) were randomized to an intervention or control group.",100.0
684,"People with MS who were medically stable were selected where cognitive function was adequate, as assessed by a Mini Mental State Examination score of 23 or over11 and had at least three identifiable physiotherapy goals were included.",fulltext,"se of arms).10 People with MS who were medically stable were selected where cognitive function was adequate, as assessed by a Mini Mental State Examination score of 23 or over11 and had at least three identiﬁable physiotherapy goal",92.27467811158799
684,"Potential subjects were excluded if they had rapidly progressing disease, were already involved in a physiotherapy programme, had additional neurological conditions or other medical conditions which would preclude them taking part in the study.",fulltext," were included. Potential subjects were excluded if they had rapidly progressing disease, were already involved in a physiotherapy programme, had additional neurological conditions or other medical conditions which would preclude them taking pa",93.44262295081968
684,Subjects were asked not to discuss their group allocation with the assessor.,fulltext,Subjects were asked not to discuss their group allocation with the assessor.,100.0
684,"All assessments were undertaken at the Douglas Grant Rehabilitation Centre, Irvine, and the assessor remained blind to the subjects’ treatment group allocation.",fulltext,"All assessments were undertaken at the Douglas Grant Rehabilitation Centre, Irvine, and the assessor remained blind to the subjects’ treatment group allocation.",100.0
684,"Subjects assigned to Group 1 received physiotherapy, twice weekly for eight weeks, by an experienced domiciliary physiotherapist within their home.",fulltext,"atch. Intervention Subjects assigned to Group 1 received physiotherapy, twice weekly for eight weeks, by an experienced domiciliary physiotherapist",87.07482993197279
684,"Each session lasted up to 60 minutes, and a task-specific programme included upper and lower limb strengthening using theraband, mobile pedals, and weights. Repetition of tasks such as sit to stand, gait, balance (using gym balls and sit fits) and stretching activities were used depending on the subjects previously identified goals.",fulltext,"within their home. Each session lasted up to 60 minutes, and a task-speciﬁc programme included upper and lower limb strengthening using theraband, mobile pedals, and weights. Repetition of tasks such as sit to stand, gait, balance (using gym balls and sit ﬁts) and stretching activities were used depending on the subjects previ",91.91616766467065
684,"The following outcome measures were recorded at baseline, post-intervention (Week 8) and at follow-up (Week 16).",fulltext,"The following outcome measures were recorded at baseline, post-intervention (Week 8) and at follow-up (Week 16).",100.0
684,"The MS impact scale (MSIS 29), which is a measure of the physical and psychological impact of MS,12 was the primary outcome measure for the study.",fulltext,"The MS impact scale (MSIS 29), which is a measure of the physical and psychological impact of MS,12 was the primary outcome measure for the study.",100.0
684,Neither of these trends reached statistical significance.,prompt,setting of the trial and the usual care settin,45.614035087719294
684,Twenty-eight subjects completed the study as two control subjects did not complete follow-up assessments (Figure 1).,fulltext,Twenty-eight subjects completed the study as two control subjects did not complete follow-up assessments (Figure 1).,100.0
685,The only selection criterion was that the diagnosis of MS was confirmed by the general practitioner. There were no exclusion criteria.,fulltext,The only selection criterion was that the diagnosis of MS was confirmed by the general practitioner. There were no exclusion criteria.,100.0
685,"Participants were volunteers with MS who were recruited through voluntary organizations, were community based and lived in West London and in counties contiguous with Greater London.",fulltext,"Participants were volunteers with MS who were recruited through voluntary organizations, were community based and lived in West London and in counties contiguous with Greater London.",100.0
685,The study was conducted with people with MS living in the community.,fulltext,The study was conducted with people with MS living in the community.,100.0
685,Sessions were conducted either at participants’ homes or in local therapy centres.,fulltext,Sessions were conducted either at participants’ homes or in local therapy centres.,100.0
685,The self-care programme primarily comprised a discussion of self-care strategies supported by an information booklet developed for the study in line with consumer priorities.,fulltext,The self-care programme primarily comprised a discussion of self-care strategies supported by an information booklet developed for the study in line with consumer priorities.,100.0
685,"The discussions lasted between 1 and 2 hours and were conducted on two occasions, over a one month period.",fulltext,"The discussions lasted between 1 and 2 hours and were conducted on two occasions, over a one month period.",100.0
685,As findings from the Delphi study highlighted the need for flexibility and responsiveness to individuals the format of the discussion focused on individuals’ interests and concerns rather than on covering all the information contained in the booklet.,fulltext,As findings from the Delphi study highlighted the need for flexibility and responsiveness to individuals the format of the discussion focused on individuals’ interests and concerns rather than on covering all the information contained in the booklet.,100.0
685,Participants were invited to join the study and were accepted when informed consent had been given in writing.,fulltext,Participants were invited to join the study and were accepted when informed consent had been given in writing.,100.0
685,Follow-up assessments were conducted six months after baseline.,fulltext,Follow-up assessments were conducted six months after baseline.,100.0
685,"Total scores on a postal version of the Barthel Index, a scale measuring mobility, the United Kingdom version of the SF-36 and one measure developed for the study; the Standard Day Dependency Record (SDDR), were the main outcome measures.",fulltext,"Total scores on a postal version of the Barthel Index,11 a scale measuring mobility,12 the United Kingdom version of the SF-3613 and one measure developed for the study; the Standard Day Dependency Record (SDDR), were the main outcome measures.",100.0
685,It was not possible to perform an ‘intention to treat’ analysis as those individuals who declined the intervention also withdrew from follow-up and therefore did not complete any follow-up assessments.,fulltext,It was not possible to perform an ‘intention to treat’ analysis as those individuals who declined the intervention also withdrew from follow-up and therefore did not complete any follow-up assessments.,100.0
686,"Inclusion criteria were: having MS (MacDonald criteria); being able to complete a questionnaire; and being in need for a multidisciplinary approach, defined by the requirement, in addition to the neurology specialist, of at least two different medical (rehabilitation specialist, neuro-urology specialist, psychiatrist) or allied health professionals (physiotherapist, occupational therapist, social worker, psychologist, and neuropsychologist). Patients who were not living independently in the community were excluded.",fulltext,"Inclusion criteria were: having MS (MacDonald criteria); being able to complete a questionnaire; and being in need for a multidisciplinary approach, defined by the requirement, in addition to the neurology specialist, of at least two different medical (rehabilitation specialist, neuro-urology specialist, psychiatrist) or allied health professionals (physiotherapist, occupational therapist, social worker, psychologist, and neuropsychologist). Patients who were not living independently in the community were excluded.",100.0
686,Signed informed consent was obtained for each patient at inclusion.,fulltext,Signed informed consent was obtained for each patient at inclusion.,100.0
686,"This prospective, randomized, controlled study is the first attempt to evaluate the multidisciplinary approach in MS patients. The results show that, contrary to our expectations, an integrated multidisciplinary approach is not superior to usual care on QoL.",fulltext,"This prospective, randomized study is the first attempt to evaluate the multidisciplinary approach in MS patients. The results show that, contrary to our expectations, an integrated multidisciplinary approach is not superior to usual care on QoL.",95.34883720930233
686,"An integrated multidisciplinary (IMD) group, consisting of an IMD approach at the Pitié-Salpêtrière MS clinic",fulltext,"An integrated multidisciplinary (IMD) group, consisting of an IMD approach at the Pitié-Salpêtrière MS clinic",100.0
686,"In the control group, interventions with the different health professionals were planned after the inclusion visit",fulltext,"In the control group, interventions with the different health professionals were planned after the inclusion visit",100.0
686,"The clinical evaluating team was masked to the treatment arm. Primary and secondary outcomes were assessed at inclusion, and after six (M6) and 12 (M12) months.",fulltext,"the committee was judged unnecessary. Primary and secondary outcomes were assessed at inclusion, and after six (M6) and 12 (M12) months.",75.625
686,The primary outcome was the impact of the strategy on quality of life (QoL) measured using the MSIS-29 scale at inclusion and after six months.,fulltext,The primary outcome was the impact of the strategy on quality of life (QoL) measured using the MSIS-29 scale at inclusion and after six months.,100.0
686,"To perform an intention-to-treat analysis, missing data were replaced with the mean variation of the group for the comparisons of the six-month variation criteria and the analysis of predictive factors of the six-month evaluation of the MSIS-29.",fulltext,"To perform an intention-to-treat analysis, missing data were replaced with the mean variation of the group for the comparisons of the six-month variation criteria and the analysis of predictive factors of the six-month evaluation of the MSIS-29.",100.0
687,"To be included in the study participants were required to have a confirmed diagnosis of MS, an Expanded Disability Status Score of between 5 and 6.5, stable drug therapy for 30 days, no relapses in the previous three months, no significant co-morbidities such as coexisting cardiac or pulmonary condition and have access to the internet via personal or tablet computer.",fulltext,"To be included in the study participants were required to have a confirmed diagnosis of MS, an Expanded Disability Status Score of between 5 and 6.5,13 stable drug therapy for 30 days, no relapses in the previous three months, no significant co-morbidities such as coexisting cardiac or pulmonary condition and have access to the internet via personal or tablet computer.",100.0
687,"Letters were sent to 138 patients from the Multiple Sclerosis Service database, thought to be suitable for the study, inviting them to participate. Of those 37 people expressed an interest in taking part.",fulltext,"Letters were sent to 138 patients from the Multiple Sclerosis Service database, thought to be suitable for the study, inviting them to participate. Of those 37 people expressed an interest in taking part.",100.0
687,Rehabilitation centre and participants’ homes.,fulltext,Rehabilitation centre and participants’ homes.,100.0
687,"Individualised therapeutic exercise programmes were developed for participants in Group 1, with exercises selected based on their baseline assessment and personal goals.",fulltext,"Individualised therapeutic exercise programmes were developed for participants in Group 1, with exercises selected based on their baseline assessment and personal goals.",100.0
687,Participants were advised to undertake the exercise programme a minimum of twice a week.,fulltext,Participants were advised to undertake the exercise programme a minimum of twice a week.,100.0
687,Outcome measures were only taken before and after the 12 week intervention.,fulltext,Outcome measures were only taken before and after the 12 week intervention.,100.0
687,"The primary outcome measure, the timed 25 foot walk, has good reliability and validity in the MS population.",fulltext,"The primary outcome measure, the timed 25 foot walk,14 has good reliability and validity in the MS population.",100.0
687,All analysis was performed on SPSS v20 with power calculations for a future fully powered trial being estimated using nQuery v7.,fulltext,All analysis was performed on SPSS v20 with power calculations for a future fully powered trial being estimated using nQuery v7.,100.0
688,"To be eligible, all patients screened for study participation had to be affected by clinically definite multiple sclerosis and live in the Rome service area.",fulltext,"To be eligible, all patients screened for study participation had to be affected by clinically definite multiple sclerosis17 and live in the Rome service area.",100.0
688,"Ninety six patients declined to participate in the study. The majority of refusers (n = 62) were young, fully ambulant, and employed.",fulltext,"Ninety six patients declined to participate. The majority of refusers (n = 62) were young, fully ambulant, and employed.",90.22556390977444
688,"Patients were recruited from the multiple sclerosis centre of the neurological department of La Sapienza University, or from other institutional centres for multiple sclerosis in Rome.",fulltext,"Patients were recruited from the multiple sclerosis centre of the neurological department of La Sapienza University, or from other institutional centres for multiple sclerosis in Rome.",100.0
688,"The study was conducted in Rome and was approved by the ethics committee of La Sapienza University. Patients were recruited from the multiple sclerosis centre of the neurological department of La Sapienza University, or from other institutional centres for multiple sclerosis in Rome.",fulltext,"The study was conducted in Rome and was approved by the ethics committee of La Sapienza University. Patients were recruited from the multiple sclerosis centre of the neurological department of La Sapienza University, or from other institutional centres for multiple sclerosis in Rome.",100.0
688,"Based on individual needs, patients randomised to home based care were followed through home visits and telephone follow up. A dedicated phone number was available five days a week from 9 am to 5 pm, where an operator addressed questions or concerns from patients and caregivers and contacted the different specialists according to the specific requirement.",fulltext,"Based on individual needs, patients randomised to home based care were followed through home visits and telephone follow up. A dedicated phone number was available five days a week from 9 am to 5 pm, where an operator addressed questions or concerns from patients and caregivers and contacted the different specialists according to the specific requirement.",100.0
688,"The home based care multidisciplinary team included two neurologists, a urologist, a rehabilitation physician, a psychologist, a physical therapist, a nurse, a social worker, and a coordinator. These were provided with cell phones and could easily be reached for advice (telephone intervention) or direct face to face intervention when required.",fulltext,"The home based care multidisciplinary team included two neurologists, a urologist, a rehabilitation physician, a psychologist, a physical therapist, a nurse, a social worker, and a coordinator. These were provided with cell phones and could easily be reached for advice (telephone intervention) or direct face to face intervention when required.",100.0
688,"After 5 pm and during the weekend an answering machine was on, and recorded messages were regularly listened to by the operator.",fulltext,"After 5 pm and during the weekend an answering machine was on, and recorded messages were regularly listened to by the operator.",100.0
688,A brief monitoring phone call once a month was used to obtain information about the patient’s medical visits and hospital admissions in the previous month.,fulltext,A brief monitoring phone call once a month was used to obtain information about the patient’s medical visits and hospital admissions in the previous month.,100.0
688,Quality of life was measured by means of the 36 item short form health survey questionnaire (SF-36).,fulltext,Quality of life was measured by means of the 36 item short form health survey questionnaire (SF-36).,100.0
689,"Participants required to have a clinical diagnosis of Multiple Sclerosis, persistent foot drop (lasting a minimum of three months) observed during a 5-minute walk test, stable disease (no change in the Extended Disability Status Score12 or relapse in previous three months), 5° of passive dorsiflexion and tolerance of functional electrical stimulation.",fulltext,"Participants required to have a clinical diagnosis of Multiple Sclerosis, persistent foot drop (lasting a minimum of three months) observed during a 5-minute walk test, stable disease (no change in the Extended Disability Status Score12 or relapse in previous three months), 5° of passive dorsiflexion and tolerance of functional electrical stimulation.",100.0
689,"Participants were excluded if they had previously used functional electrical stimulation or an ankle-foot orthosis for foot drop, moderate to severe cognitive impairment (scored < 26, Montreal Cognitive Assessment),13 foot drop due to other disorders, other conditions significantly affecting gait, contraindications to functional electrical stimulation, marked proximal weakness, plantar flexor spasticity, stance phase instability or severe lower limb/trunk ataxia affecting gait.",fulltext,"Participants were excluded if they had previously used functional electrical stimulation or an ankle-foot orthosis for foot drop, moderate to severe cognitive impairment (scored < 26, Montreal Cognitive Assessment),13 foot drop due to other disorders, other conditions significantly affecting gait, contraindications to functional electrical stimulation, marked proximal weakness, plantar flexor spasticity, stance phase instability or severe lower limb/trunk ataxia affecting gait.",100.0
689,"Potential participants known to Multiple Sclerosis healthcare practitioners working across seven outpatient centres in Scotland – Ayrshire & Arran, Greater Glasgow & Clyde, Dumfries and Galloway, Lanarkshire, Lothian, Fife and Tayside – were informed of the study and issued with a participant information sheet.",fulltext,"Potential participants known to Multiple Sclerosis healthcare practitioners working across seven outpatient centres in Scotland – Ayrshire & Arran, Greater Glasgow & Clyde, Dumfries and Galloway, Lanarkshire, Lothian, Fife and Tayside – were informed of the study and issued with a participant information sheet.",100.0
689,Potential participants contacted the researchers if they were interested in participating.,fulltext,Potential participants contacted the researchers if they were interested in participating.,100.0
689,"This study was prospectively registered with the UK Clinical Trials Gateway (Identifier: 15884) https://www.ukctg.nihr.ac.uk/clinical-trials/search-for-a-clinical-trial/. The study was funded by the Multiple Sclerosis Society, UK (Grant Reference: 001). It commenced on 1 April 2014 and was completed on 31 March 2018. Ethical approval was granted by the West of Scotland Research Ethics Committee (14/WS/0014) and the study was sponsored by NHS Ayrshire and Arran Research and Development department.",fulltext,"This study was prospectively registered with the UK Clinical Trials Gateway (Identifier: 15884) https://www.ukctg.nihr.ac.uk/clinical-trials/search-for-a-clinical-trial/. The study was funded by the Multiple Sclerosis Society, UK (Grant Reference: 001). It commenced on 1 April 2014 and was completed on 31 March 2018. Ethical approval was granted by the West of Scotland Research Ethics Committee (14/WS/0014) and the study was sponsored by NHS Ayrshire and Arran Research and Development department.",100.0
689,"A multicentre design of this study enhances the generalizability of results. However, although the ankle-foot orthoses prescription was standardized, variations did occur across sites.",fulltext,"The multicentre design of this study enhances the generalizability of results. However, although the ankle-foot orthoses prescription was standardized, variations did occur across sit",97.82608695652173
689,"Participants randomized to the usual care group were fitted with a custom-made, solid, ankle-foot orthosis by an orthotist, within four weeks of their initial assessment. The recommendations made by the Best Practice Statement for ankle-foot orthoses following stroke were applied.",fulltext,"Participants randomized to the usual care group were fitted with a custom-made, solid, ankle-foot orthosis by an orthotist, within four weeks of their initial assessment. The recommendations made by the Best Practice Statement for ankle-foot orthoses following stroke were applied.",100.0
689,"The angle of the tibia was inclined forward, approximately 10° to vertical, and each orthosis was ‘tuned’ by the addition or removal of small heel wedges.",fulltext,"The angle of the tibia was inclined forward, approximately 10° to vertical, and each orthosis was ‘tuned’ by the addition or removal of small heel wedges.",100.0
689,"Participants randomized to the functional electrical stimulation group were assessed and fitted with an Odstock Dropped Foot Stimulator Pace (OML, Salisbury) device by a physiotherapist experienced in functional electrical stimulation (A.L.). Wired heel switches and a stimulation frequency of 40 Hz were applied. Electrode position, pulse width, waveform and ramping parameters were adjusted for each participant in order to achieve a comfortable and efficient muscle contraction. The current amplitude ranged from 7 to 72 mA (mean = 40 mA).",fulltext,"Participants randomized to the functional electrical stimulation group were assessed and fitted with an Odstock Dropped Foot Stimulator Pace (OML, Salisbury) device by a physiotherapist experienced in functional electrical stimulation (A.L.). Wired heel switches and a stimulation frequency of 40 Hz were applied. Electrode position, pulse width, waveform and ramping parameters were adjusted for each participant in order to achieve a comfortable and efficient muscle contraction. The current amplitude ranged from 7 to 72 mA (mean = 40 mA).",100.0
689,Participants in both groups were instructed to gradually increase the wear of their devices over the first six weeks.,fulltext,Participants in both groups were instructed to gradually increase the wear of their devices over the first six weeks.,100.0
689,"Outcome measures were administered by two unblinded assessors (Rebecca Hunter and A.L.) at baseline (0), 3, 6 and 12 months, except for the Psychological Impact of Assistive Devices Score15 which was administered at 12 months only.",fulltext,"Outcome measures were administered by two unblinded assessors (Rebecca Hunter and A.L.) at baseline (0), 3, 6 and 12 months, except for the Psychological Impact of Assistive Devices Score15 which was administered at 12 months only.",100.0
689,"For the Timed 25 Foot Walk, participants walked along a 25 foot course ‘as quickly as possible, but safely’. The test was repeated four times, twice with and twice without the device.",fulltext,"For the Timed 25 Foot Walk, participants walked along a 25 foot course ‘as quickly as possible, but safely’. The test was repeated four times, twice with and twice without the device.",100.0
689,"The primary outcome was walking speed as measured by the 5-minute self-selected walk test. Participants walked twice, once with their device and once without, resting for 20 minutes between. The order of testing was randomized between participants but was kept consistent for each participant throughout the trial. Participants walked at their preferred walking speed around a 9.5 m elliptical course for 5 minutes, resulting in a 10-meter shuttle length. The total distance walked was recorded and the mean walking speed (m/s) calculated.",fulltext,"The primary outcome was walking speed as measured by the 5-minute self-selected walk test. Participants walked twice, once with their device and once without, resting for 20 minutes between. The order of testing was randomized between participants but was kept consistent for each participant throughout the trial. Participants walked at their preferred walking speed around a 9.5 m elliptical course for 5 minutes, resulting in a 10-meter shuttle length. The total distance walked was recorded and the mean walking speed (m/s) calculated.",100.0
689,A Restricted Maximum Likelihood approach to fitting mixed models was employed to allow intention to treat assumptions to cope with missing data.,fulltext,A Restricted Maximum Likelihood approach to fitting mixed models was employed to allow intention to treat assumptions to cope with missing data.,100.0
690,"Participants were non-institutionalized adults (age ⩾ 18 years) with severe MS and their primary carers. Other patient inclusion criteria were primary or secondary progressive MS,1,13 Expanded Disability Status Scale (EDSS) score ⩾ 8.0,14 complex symptoms,15 and ⩾2 unmet care needs.16 The carer (a family member, relative, or friend of the patient) was his or her next of kin and was designated by the patient except for patients with severe cognitive compromise.",fulltext,"Participants were non-institutionalized adults (age ⩾ 18 years) with severe MS and their primary carers. Other patient inclusion criteria were primary or secondary progressive MS,1,13 Expanded Disability Status Scale (EDSS) score ⩾ 8.0,14 complex symptoms,15 and ⩾2 unmet care needs.16 The carer (a family member, relative, or friend of the patient) was his or her next of kin and was designated by the patient except for patients with severe cognitive compromise.",100.0
690,"Based on the principles of PC,17 each center had a HPA team consisting of a physician (neurologist or physiatrist), a nurse (case manager and team leader), a psychologist, and a social worker. Nurses of the Milan and Rome centers had degrees and worked full time in PC; the Catania nurse attended a week-long individual training course. Prior to study start, all team members were trained in the HPA intervention; 3 and 6 months after trial initiation they met again to share experiences, fine-tune the protocol, and discuss difficult cases.",fulltext,"Based on the principles of PC,17 each center had a HPA team consisting of a physician (neurologist or physiatrist), a nurse (case manager and team leader), a psychologist, and a social worker. Nurses of the Milan and Rome centers had degrees and worked full time in PC; the Catania nurse attended a week-long individual training course. Prior to study start, all team members were trained in the HPA intervention; 3 and 6 months after trial initiation they met again to share experiences, fine-tune the protocol, and discuss difficult cases.",100.0
690,"UC consisted of the health and social services provided by the Italian National Health Service in the study area. Dyads assigned to UC received the three examiner visits (visits 1–3) and the monthly telephone interviews, but not the HPA team visits (except visit 0).",fulltext,"UC consisted of the health and social services provided by the Italian National Health Service in the study area. Dyads assigned to UC received the three examiner visits (visits 1–3) and the monthly telephone interviews, but not the HPA team visits (except visit 0).",100.0
690,"After a comprehensive assessment of the dyad needs based on direct observation and on visit 1 information (available via the eCRF), the HPA team defined the contents of the intervention, involving the dyad and the patient caring physician (the intervention was not intended to replace existing services). Subsequently, the team verified program implementation and reviewed it as necessary.",fulltext,"After a comprehensive assessment of the dyad needs based on direct observation and on visit 1 information (available via the eCRF), the HPA team defined the contents of the intervention, involving the dyad and the patient caring physician (the intervention was not intended to replace existing services). Subsequently, the team verified program implementation and reviewed it as necessary.",100.0
690,"Dyads assigned to UC received the three examiner visits (visits 1–3) and the monthly telephone interviews, but not the HPA team visits (except visit 0).",fulltext,"Dyads assigned to UC received the three examiner visits (visits 1–3) and the monthly telephone interviews, but not the HPA team visits (except visit 0).",100.0
690,"The pre-specified primary endpoints were changes in patient quality of life (SEIQoL-DW) and symptom burden (PC Outcome Scale-Symptoms-MS, POS-S-MS).",fulltext,"The pre-specified primary endpoints were changes in patient quality of life (SEIQoL-DW) and symptom burden (PC Outcome Scale-Symptoms-MS, POS-S-MS).",100.0
690,"All randomly assigned patients were included in the main intention-to-treat analysis, provided that at least one contact with the team occurred (HPA group).",fulltext,"All randomly assigned patients were included in the main intention-to-treat analysis, provided that at least one contact with the team occurred (HPA group).",100.0
691,"The main inclusion criteria were: (1) clinically definite MS diagnosis, (2) fatigue impacting on daily life (Fatigue Severity Scale total score >4)16 and (3) ambulatory. The main exclusion criteria were: (1) having taken part in a fatigue programme in the last year, (2) cognitive impairments, (3) a relapse in the previous 3 months or (4) having started treatment with disease modifying or antidepressant drugs within the previous 3 months.",fulltext,"The main inclusion criteria were: (1) clinically definite MS diagnosis, (2) fatigue impacting on daily life (Fatigue Severity Scale total score >4)16 and (3) ambulatory. The main exclusion criteria were: (1) having taken part in a fatigue programme in the last year, (2) cognitive impairments, (3) a relapse in the previous 3 months or (4) having started treatment with disease modifying or antidepressant drugs within the previous 3 months.",100.0
691,"Participants were recruited in three UK centres (Poole, Bristol, Southampton/Portsmouth) from primary or secondary care, or via MS Society newsletters/websites.",fulltext,"Participants were recruited in three UK centres (Poole, Bristol, Southampton/Portsmouth) from primary or secondary care, or via MS Society newsletters/websites.",100.0
691,"FACETS was delivered in hotel meeting-room facilities, with the exception of one centre, where it was held in a rehabilitation hospital.",fulltext,"FACETS was delivered in hotel meeting-room facilities, with the exception of one centre, where it was held in a rehabilitation hospital.",100.0
691,"The FACETS intervention uses health professionals routinely involved in managing MS, supported by a clinical psychologist.",fulltext,"The FACETS intervention uses health professionals routinely involved in managing MS, supported by a clinical psychologist.",100.0
691,"Apart from one MS specialist nurse, facilitators were either occupational therapists or physiotherapists. Facilitators were all qualified to a senior/advanced level (in the UK minimum of a Band 7 on the NHS Agenda for Change (AfC) grading structure).",fulltext,"Apart from one MS specialist nurse, facilitators were either occupational therapists or physiotherapists. Facilitators were all qualified to a senior/advanced level (in the UK minimum of a Band 7 on the NHS Agenda for Change (AfC) grading structure).",100.0
691,"The intervention consists of six sessions (∼90 min duration) held weekly and facilitated in groups of 6–12 by two health professionals with experience of working with people with MS and group-work (such as occupational therapists, nurses or physiotherapists). The intervention is highly structured. Each session follows the same general format, namely, facilitator-delivered presentations, flipchart discussions, group activities and homework. The facilitator manual provides guidance on preparation and delivery, detailed session content, notes and suggested timings, and a checklist of facilitator objectives as well as signposts to additional resources. Sessions are delivered via PowerPoint; hence can be replicated. A companion participant handbook, along with existing information booklets, reinforces programme content.",fulltext,"The intervention consists of six sessions (∼90 min duration) held weekly and facilitated in groups of 6–12 by two health professionals with experience of working with people with MS and group-work (such as occupational therapists, nurses or physiotherapists). The intervention is highly structured. Each session follows the same general format, namely, facilitator-delivered presentations, flipchart discussions, group activities and homework. The facilitator manual provides guidance on preparation and delivery, detailed session content, notes and suggested timings, and a checklist of facilitator objectives as well as signposts to additional resources. Sessions are delivered via PowerPoint; hence can be easily replicated. A companion participant handbook, along with existing information booklets, reinforces programme content.",100.0
691,Individuals who had attended a fatigue management programme in the past year were excluded from the trial as were those who had received a fatigue intervention from a health professional in the past 3 months (see protocol).,fulltext,Individuals who had attended a fatigue management programme in the past year were excluded from the trial as were those who had received a fatigue intervention from a health professional in the past 3 months (see protocol).,100.0
691,"Primary outcome measures: These were: (1) fatigue severity (Global Fatigue Severity (GFS) subscale of the Fatigue Assessment Instrument (FAI)),18 (2) disease-specific quality of life (QOL) (total score on the Multiple Sclerosis Impact Scale, V.1 (MSIS-29, V.1))19 and (3) self-efficacy for managing fatigue (Multiple Sclerosis-Fatigue Self-Efficacy scale—adapted from the Control subscale of the MS Self-Efficacy scale).",fulltext,"Primary outcome measures: These were: (1) fatigue severity (Global Fatigue Severity (GFS) subscale of the Fatigue Assessment Instrument (FAI)),18 (2) disease-specific quality of life (QOL) (total score on the Multiple Sclerosis Impact Scale, V.1 (MSIS-29, V.1))19 and (3) self-efficacy for managing fatigue (Multiple Sclerosis-Fatigue Self-Efficacy scale—adapted from the Control subscale of the MS Self-Efficacy scale).",100.0
691,The main analysis was intention-to-treat but we also conducted a ‘per protocol’ analysis (excluding participants who attended fewer than four FACETS sessions).,fulltext,The main analysis was intention-to-treat but we also conducted a ‘per protocol’ analysis (excluding participants who attended fewer than four FACETS sessions).,100.0
692,"Inclusion criteria for the study included (1) a diagnosis of MS, (2) not currently engaged in rehabilitation, therapy or PA program and able to undertake PA without risk-factors (3) aged between 18 and 65 (4) able to give informed consent and to understand French.",fulltext,"Inclusion criteria for the study included (1) a diagnosis of MS, (2) not currently engaged in rehabilitation, therapy or PA program and able to undertake PA without risk-factors (3) aged between 18 and 65 (4) able to give informed consent and to understand French.",100.0
692,"Participants were recruited from two hospitals in the Parisian region, in France receiving outpatient services for MS at a regional medical center.",fulltext,"Participants were recruited from two hospitals in the Parisian region, in France receiving outpatient services for MS at a regional medical center.",100.0
692,"Practicing sessions were conducted under the supervision of a physical and sports activity trainer specializing in sports training. Participants were randomly assigned to one of the three experimental groups: MBI group, II group or Control Group (CG) (n = 12).",fulltext,"Practicing sessions were conducted under the supervision of a physical and sports activity trainer specializing in sports training. Participants were randomly assigned to one of the three experimental groups: MBI group, II group or Control Group (CG) (n = 12).",100.0
692,"Mindfulness practice took place individually at home six times per week, without any assistance.",fulltext,"Mindfulness practice took place individually at home six times per week, without any assistance.",100.0
692,All measurements were carried out at two phases of the study T1 (baseline) and T2 (eight weeks after randomization).,fulltext,All measurements were carried out at two phases of the study T1 (baseline) and T2 (eight weeks after randomization).,100.0
692,"Mobility, fatigue, and the impact of the disease on the patient’s life were measured.",fulltext,"Mobility, fatigue, and the impact of the disease on the patient’s life were measured.",100.0
692,"According to the recommendations of McCoy (2017), concerning the randomized controlled trials and the assess of the psychological interventions efficacy all the patients of the study were analyzed.",fulltext,"According to the recommendations of McCoy (2017), concerning the randomized controlled trials and the assess of the psychological interventions efficacy all the patients of the study were analyzed.",100.0
693,"20 subjects with relapsing–remitting or progressive MS, 26–50 years of age, with EDSS ≤ 6 and EDSS pyramidal functions score (EDSSpyr) > 2 were enrolled in a randomized prospective study.",fulltext,"20 subjects with relapsing–remitting or progressive MS, 26–50 years of age, with EDSS ≤ 6 and EDSS pyramidal functions score (EDSSpyr) > 2 were enrolled in a randomized prospective study.",100.0
693,Participants gave their written consent prior to the inclusion.,fulltext,Participants gave their written consent prior to the inclusion.,100.0
693,The study was approved by the National Medical Ethics Committee.,fulltext,The study was approved by the National Medical Ethics Committee.,100.0
693,"SC took place in the Training, Occupation and Care Centre under the supervision of two SC instructors with a Slovenian Sports Climbing Committee License. The climbing wall with an inclination of 90° and the height of 5 m was adjusted for patients with physical disabilities by adding numerous and bigger holds.",fulltext,"SC took place in the Training, Occupation and Care Centre under the supervision of two SC instructors with a Slovenian Sports Climbing Committee License. The climbing wall with an inclination of 90° and the height of 5 m was adjusted for patients with physical disabilities by adding numerous and bigger holds.",100.0
693,"Hatha yoga took place in the facilities of Institute of Rehabilitation, Republic of Slovenia. The program was adjusted for MS patients and was held by a MS specialist nurse who is a yoga instructor with a license for patients with physical disabilities.",fulltext,"Hatha yoga took place in the facilities of Institute of Rehabilitation, Republic of Slovenia. The program was adjusted for MS patients and was held by a MS specialist nurse who is a yoga instructor with a license for patients with physical disabilities.",100.0
693,"SC took place in the Training, Occupation and Care Centre under the supervision of two SC instructors with a Slovenian Sports Climbing Committee License.",fulltext,"SC took place in the Training, Occupation and Care Centre under the supervision of two SC instructors with a Slovenian Sports Climbing Committee License.",100.0
693,"Hatha yoga took place in the facilities of Institute of Rehabilitation, Republic of Slovenia. The program was adjusted for MS patients and was held by a MS specialist nurse who is a yoga instructor with a license for patients with physical disabilities.",fulltext,"Hatha yoga took place in the facilities of Institute of Rehabilitation, Republic of Slovenia. The program was adjusted for MS patients and was held by a MS specialist nurse who is a yoga instructor with a license for patients with physical disabilities.",100.0
693,"Examinations were performed by the members of Multiple Sclerosis Center at the Division of Neurology, University Medical Center Ljubljana. We used the following assessment tools and procedures:",fulltext,"Examinations were performed by the members of Multiple Sclerosis Center at the Division of Neurology, University Medical Center Ljubljana. We used the following assessment tools and procedures:",100.0
693,"To what extent is the trial's primary outcome relevant to participants? For example, score 5 for a very pragmatic choice where the outcome is of obvious importance to participants; score 1 for a very explanatory approach using a surrogate, physiological outcome, central adjudication or use assessment expertise that is not available in usual care, or the outcome is measured at an earlier time than in usual care.",prompt,"To what extent is the trial's primary outcome relevant to participants? For example, score 5 for a very pragmatic choice where the outcome is of obvious importance to participants; score 1 for a very explanatory approach using a surrogate, physiological outcome, central adjudication or use assessment expertise that is not available in usual care, or the outcome is measured at an earlier time than in usual care.",100.0
694,MS patients older than 18 years who had a confirmed MS with spasticity of the lower limbs and an Expanded Disability Status Scale (EDSS) score between 4 and 6.5 were eligible for inclusion.,fulltext,MS patients older than 18 years who had a confirmed MS with spasticity of the lower limbs and an Expanded Disability Status Scale (EDSS)9 score between 4 and 6.5 were eligible for inclusion.,100.0
694,Eligible patients were randomized to one of the two groups using sealed opaque envelopes on the basis of a computer-generated randomization list.,fulltext,Eligible patients were randomized to one of the two groups using sealed opaque envelopes on the basis of a computer-generated randomization list.,100.0
694,"The study was conducted at five sites in Germany, all of which have hippotherapy experience as stipulated by the rules of the German Consortium for Therapeutic Riding.",fulltext,"The study was conducted at five sites in Germany, all of which have hippotherapy experience as stipulated by the rules of the German Consortium for Therapeutic Riding.",100.0
694,"Patients of the intervention group received hippotherapy (as defined by the regulations for hippotherapy of the Deutsches Kuratorium für Therapeutisches Reiten e.V. (DKThR)) once a week for 12 weeks as an add-on therapy to their standard care, which remained unchanged.",fulltext,"Patients of the intervention group received hippotherapy (as defined by the regulations for hippotherapy of the Deutsches Kuratorium für Therapeutisches Reiten e.V. (DKThR))8 once a week for 12 weeks as an add-on therapy to their standard care, which remained unchanged.",100.0
694,"Hippotherapy was provided by existing staff at the participating centers, following standard regulations.",fulltext,pplied. The study was approved by the respective ethical committees of the participating sites and reg,57.14285714285714
694,"Examinations and questionnaires were completed prior to the first hippotherapy session (baseline), after 6–7 weeks (interim assessment) and after 12 weeks (final assessment).",fulltext,"Examinations and questionnaires were completed prior to the first hippotherapy session (baseline), after 6–7 weeks (interim assessment) and after 12 weeks (final assessment).",100.0
694,The primary endpoint was the change in the BBS (difference from BBS baseline to week 12).,fulltext,The primary endpoint was the change in the BBS10–13 (difference from BBS baseline to week 12).,100.0
694,Analyses were based on the modified intention-to-treat set (modified ITT).,fulltext,Analyses were based on the modified intention-to-treat set (modified ITT).,100.0
695,"In order to preserve a focus on primarily physical disabilities, dementing disorders such as Alzheimer's disease were not included.",fulltext,"In order to preserve a focus on primarily physical disabilities, dementing disorders such as Alzheimer's disease were not included.",100.0
695,"Participants whose clinical features appeared incompatible with the recorded diagnosis were excluded, as were those with neurological complications of primarily non-neurological conditions such as diabetes mellitus, or additional causes of severe disability.",fulltext,"Participants whose clinical features appeared incompatible with the recorded diagnosis were excluded, as were those with neurological complications of primarily non-neurological conditions such as diabetes mellitus, or additional causes of severe disability.",100.0
695,From July 1998 we approached the 177 GPs based within the City of Nottingham boundaries (population 282000)...We searched practice diagnostic lists and prescription records and made intensive enquiries for additional patients from individual GPs.,fulltext,. We searched practice diagnostic lists and prescription records and made intensive enquiries for additional patients from individual GPs.,56.09756097560976
695,"The study took place between August 1997 and March 2000 and was approved by the research ethics committee of Queen's Medical Centre (Nottingham, UK).",fulltext,"The study took place between August 1997 and March 2000 and was approved by the research ethics committee of Queen's Medical Centre (Nottingham, UK).",100.0
695,"Within six weeks of the baseline visit, participants in the EG received an education visit from the research OT, who provided personalized advice and information...",fulltext,"Within six weeks of the baseline visit, participants in the EG received an education visit from the research OT, who provided personalized advice and information ",98.78048780487805
695,"Within six weeks of the baseline visit, participants in the EG received an education visit from the research OT, who provided personalized advice and information based on the expert panel discussion, a tailored version of the standard information package, and a specially constructed leaflet offering information about the participant's condition and about self-help organizations.",fulltext,"Within six weeks of the baseline visit, participants in the EG received an education visit from the research OT, who provided personalized advice and information based on the expert panel discussion, a tailored version of the standard information package, and a specially constructed leaflet offering information about the participant's condition and about self-help organizations.",100.0
695,"Approximately two weeks later, EG participants received a single follow-through phone call from the research OT to confirm and reinforce the educational content of the visit...",fulltext,"Approximately two weeks later, EG participants received a single follow-through phone call from the research OT to confirm and reinforce the educational content of the visit, ",99.43181818181817
695,Information on adverse events was collected by phone at two-monthly intervals between baseline and 12-month assessments.,fulltext,Information on adverse events was collected by phone at two-monthly intervals between baseline and 12-month assessments.,100.0
695,We assessed participants at baseline and 12 months later.,fulltext, Participants were assessed at baseline and 12 months later.,80.70175438596492
695,Primary outcome measures were reports of one or more falls or skin sores.,fulltext,Primary outcome measures were reports of one or more falls or skin sores.,100.0
695,Analyses were performed both with and without adjustment for baseline rates of events in the groups.,fulltext,Analyses were performed both with and without adjustment for baseline rates of events in the groups.,100.0
696,"Inclusion criteria consisted of: a diagnosis of relapsing MS according to McDonald criteria, being on natalizumab therapy for 24 months or longer, aged between 18 and 65 years and an EDSS score of ≤7.0.",fulltext,"Inclusion criteria consisted of: a diagnosis of relapsing MS according to McDonald criteria,19 being on natalizumab therapy for 24 months or longer, aged between 18 and 65 years and an EDSS score of ≤7.0.",100.0
696,"Fifty patients with relapsing MS, followed at the Jacobs MS Center for Treatment and Research, Department of Neurology, University at Buffalo, Buffalo New York, USA, were enrolled in this study.",fulltext,"Fifty patients with relapsing MS, followed at the Jacobs MS Center for Treatment and Research, Department of Neurology, University at Buffalo, Buffalo New York, USA, were enrolled in this study.",100.0
696,"This was a prospective, phase IV, 12-month, open-label, single center single-blinded (MRI) randomised study.",fulltext,"This was a prospective, phase IV, 12-month, open-label, single center single-blinded (MRI) randomised study.",100.0
696,"Standardised MRI were performed using the same 3 T General Electric Signa Excite HD 12.0 (General Electric, Milwaukee, Wisconsin, USA) right-handed scanner using a multichannel head and neck coil at baseline, 6 and 12 months following the discontinuation of natalizumab therapy.",fulltext,"Standardised MRI were performed using the same 3 T General Electric Signa Excite HD 12.0 (General Electric, Milwaukee, Wisconsin, USA) right-handed scanner using a multichannel head and neck coil at baseline, 6 and 12 months following the discontinuation of natalizumab therapy.",100.0
696,"IDG: Patients who discontinued natalizumab therapy at once and initiated another DMT (interferon, GA therapy or an oral DMT- fingolimod, dimethyl fumatate or teriflunomide) at 1–6 months following the last natalizumab infusion (1–2 months for the injectable DMTs and 3–6 months for the oral DMTs) and tapered group (TG): patients administered two additional natalizumab infusions, one at 6 weeks and one at 8 weeks (14 weeks from study entry).",fulltext,"IDG: Patients who discontinued natalizumab therapy at once and initiated another DMT (interferon, GA therapy or an oral DMT- fingolimod, dimethyl fumatate or teriflunomide) at 1–6 months following the last natalizumab infusion (1–2 months for the injectable DMTs and 3–6 months for the oral DMTs) and tapered group (TG): patients administered two additional natalizumab infusions, one at 6 weeks and one at 8 weeks (14 weeks from study entry).",100.0
696,Treatment compliance was assessed by interviews during scheduled visits.,fulltext,Treatment compliance was assessed by interviews during scheduled visits.,100.0
696,"A physical examination and neurological assessment was administered at baseline, 3, 6 and 12 months postdiscontinuation (counted from the last natalizumab infusion), as well as during unscheduled visits due to relapses (within 3–5 days of any new symptom development).",fulltext,"A physical examination and neurological assessment was administered at baseline, 3, 6 and 12 months postdiscontinuation (counted from the last natalizumab infusion), as well as during unscheduled visits due to relapses (within 3–5 days of any new symptom development).",100.0
696,Safety parameters evaluated as primary outcomes were defined as: (1) MRI parameters quantified by lesion activity analyses and changes in lesion volume (LV) and (2) clinical parameters that included the number of clinical relapses during the cessation period compared to the number of relapses before cessation in both the group as a whole as well as between the two randomised groups.,fulltext,Safety parameters evaluated as primary outcomes were defined as: (1) MRI parameters quantified by lesion activity analyses and changes in lesion volume (LV) and (2) clinical parameters that included the number of clinical relapses during the cessation period compared to the number of relapses before cessation in both the group as a whole as well as between the two randomised groups.,100.0
697,"Inclusion criteria were the following: diagnosis of MS made by a neurologist, able to walk 10 meters with or without an aid within 2 minutes, no relapse of their MS in the past 4 weeks, and no other neurological or orthopedic condition that would affect their function.",fulltext,"Inclusion criteria were the following: diagnosis of MS made by a neurologist, able to walk 10 meters with or without an aid within 2 minutes, no relapse of their MS in the past 4 weeks, and no other neurological or orthopedic condition that would affect their function.",100.0
697,"Eligible participants were excluded from the study if they were already engaged in a formal exercise program lasting >30 minutes twice per week, experienced an exacerbation within the past 4 weeks, had their MS immunomodulation medications altered in the previous 4 weeks or during the trial period, or declined to be randomly allocated.",fulltext,"Eligible participants were excluded from the study if they were already engaged in a formal exercise program lasting >30 minutes twice per week, experienced an exacerbation within the past 4 weeks, had their MS immunomodulation medications altered in the previous 4 weeks or during the trial period, or declined to be randomly allocated.",100.0
697,Community dwelling people with MS were recruited through the Multiple Sclerosis Society of New South Wales and South Australia.,fulltext,Community dwelling people with MS were recruited through the Multiple Sclerosis Society of New South Wales and South Australia.,100.0
697,The group program was conducted at a local community center and included four to six participants per class.,fulltext,The group program was conducted at a local community center and included four to six participants per class.,100.0
697,"Groups were led by a physiotherapist employed by the Multiple Sclerosis Society who received training to ensure a standard approach to intervention, intensity, and progression.",fulltext,"Groups were led by a physiotherapist employed by the Multiple Sclerosis Society who received training to ensure a standard approach to intervention, intensity, and progression.",100.0
697,"Guidelines were provided to physiotherapists and participants for exercises to be adapted and progressed to suit individual functional ability via increasing repetitions, amplitude of movement, speed of movement, and modifying base of support.",fulltext,"Guidelines were provided to physiotherapists and participants for exercises to be adapted and progressed to suit individual functional ability via increasing repetitions, amplitude of movement, speed of movement, and modifying base of support.",100.0
697,"Exercises were aimed at improving gait speed, endurance, and balance. They were individualized, specific, progressed in load, and performed at a moderate to high intensity.",fulltext,"Exercises were aimed at improving gait speed, endurance, and balance. They were individualized, specific, progressed in load, and performed at a moderate to high intensity.",100.0
697,"In both group and home exercise sessions, participants completed eight, 6 minute exercises/stations per session plus a 5-minute warm up and cool down as outlined in the Appendix S1.",fulltext,"In both group and home exercise sessions, participants completed eight, 6 minute exercises/stations per session plus a 5-minute warm up and cool down as outlined in the Appendix S1.",100.0
697,"Outcome assessments were conducted at baseline, immediately postintervention and at 8-week follow-up.",fulltext,"Outcome assessments were conducted at baseline, immediately postintervention and at 8-week follow-up.",100.0
697,Adherence (proportion of exercise sessions completed) was recorded in both groups.,fulltext,Adherence (proportion of exercise sessions completed) was recorded in both groups.,100.0
697,"The primary outcome measure was gait speed, measured using the 10-meter walk test.",fulltext,"The primary outcome measure was gait speed, measured using the 10-meter walk test.",100.0
697,Data were analyzed according to the intention-to-treat principle.,fulltext,Data were analyzed according to the intention-to-treat principle.,100.0
705,Male fans of two ice hockey teams (35–65 yr; body mass index ≥28 kg·m−2) located in Ontario (Canada) were randomized to intervention (Hockey FIT) or comparator (wait-list control).,fulltext,Male fans of two ice hockey teams (35–65 yr; body mass index ≥28 kg·m−2) located in Ontario (Canada) were randomized to intervention (Hockey FIT) or comparator (wait-list control).,100.0
705,"Eligible participants were male 35–65 yr old with a BMI of ≥28 kg·m−2 and met PA safety requirements (i.e., no risk indicated by the Physical Activity Readiness Questionnaire [36] or clearance from a health care provider).",fulltext,"Eligible participants were male 35–65 yr old with a BMI of ≥28 kg·m−2 and met PA safety requirements (i.e., no risk indicated by the Physical Activity Readiness Questionnaire [36] or clearance from a health care provider).",100.0
705,"Recruitment occurred using a variety of methods (e.g., hockey team e-mail blasts and social media accounts, study Web site (http://hockeyfansintraining.org/), posters, traditional media advertisements, word of mouth, direct contact at team arena).",fulltext,"Recruitment occurred using a variety of methods (e.g., hockey team e-mail blasts and social media accounts, study Web site (http://hockeyfansintraining.org/), posters, traditional media advertisements, word of mouth, direct contact at team arena).",100.0
705,"We used a pragmatic approach for the program venue at each site, using a combination of the hockey team’s arena and an affiliated health club facility.",fulltext,"We used a pragmatic approach for the program venue at each site, using a combination of the hockey team’s arena and an affiliated health club facility.",100.0
705,"Program sessions comprised the following: 1) classroom-based teaching of behavior change techniques and simple information sharing on PA and healthy eating, delivered to encourage participant interaction and mutual learning, and 2) exercise sessions where men performed aerobic, strength, and flexibility exercises, incorporating their passion for hockey off the ice. Sessions were designed to appeal to men; they included elements of friendly competition and encouraged banter, humor, and peer support.",fulltext,"Program sessions comprised the following: 1) classroom-based teaching of behavior change techniques and simple information sharing on PA and healthy eating, delivered to encourage participant interaction and mutual learning, and 2) exercise sessions where men performed aerobic, strength, and flexibility exercises, incorporating their passion for hockey off the ice. Sessions were designed to appeal to men; they included elements of friendly competition and encouraged banter, humor, and peer support.",100.0
705,"Measurement at baseline and 12 wk (both groups) and 12 months (intervention group only) included clinical outcomes (e.g., weight) and self-reported physical activity, diet, and self-rated health.",fulltext,"Measurement at baseline and 12 wk (both groups) and 12 months (intervention group only) included clinical outcomes (e.g., weight) and self-reported physical activity, diet, and self-rated health.",100.0
705,The planned primary outcome for the definitive trial was the difference between groups in mean weight loss (kg) and percentage weight change from baseline to 12 wk.,fulltext,The planned primary outcome for the definitive trial was the difference between groups in mean weight loss (kg) and percentage weight change from baseline to 12 wk.,100.0
705,"Percentage of baseline weight was examined using an ANCOVA, and total PA from the IPAQ was analyzed using quantile regression; all models adjusted for age, site, and either baseline weight (weight model) or baseline total PA (total PA model).",fulltext,"Percentage of baseline weight was examined using an ANCOVA, and total PA from the IPAQ was analyzed using quantile regression; all models adjusted for age, site, and either baseline weight (weight model) or baseline total PA (total PA model).",100.0
705,We analyzed outcome data to examine the potential effectiveness of the Hockey FIT program on the basis of an intent-to-treat approach.,fulltext,We analyzed outcome data to examine the potential effectiveness of the Hockey FIT program on the basis of an intent-to-treat approach.,100.0
712,"We selected 156 pregnant women in their ≥ 37 week/s, who had cervical dilations of ≥ 4 cm and with two or more contractions in 10 minutes.",fulltext,"We selected 156 pregnant women in their ≥ 37 week/s, who had cervical dilations of ≥ 4 cm and with two or more contractions in 10 minutes.",100.0
712,"Those with the following were excluded: serious preeclampsia, placenta previa, immediate indication of cesarean, dilations at ≥ 8 cm and those that used analgesics for less than six hours from the study admission time.",fulltext,"Those with the following were excluded: serious preeclampsia, placenta previa, immediate indication of cesarean, dilations at ≥ 8 cm and those that used analgesics for less than six hours from the study admission time.",100.0
712,The pregnant women in labor were allocated through a sequential list of random numbers in blocks of six patients generated using the program Excel(r) and they were distributed in three groups,fulltext,The pregnant women in labor were allocated through a sequential list of random numbers in blocks of six patients generated using the program Excel(r) and they were distributed in three groups,100.0
712,"It was carried out between January and August of 2013. The subjects were pregnant women admitted to a teaching tertiary public hospital on the outskirts of the state of Sao Paulo, Brazil.",fulltext,"It was carried out between January and August of 2013. The subjects were pregnant women admitted to a teaching tertiary public hospital on the outskirts of the state of Sao Paulo, Brazil.",100.0
712,"Where the study was carried out, the following was permitted: the presence of someone to accompany the pregnant lady, the use of methods other than drugs such as taking a shower, massages in the lower back region and breathing exercises as well as liberty of movement (in cases where this did not go against medical advice).",fulltext,"Where the study was carried out, the following was permitted: the presence of someone to accompany the pregnant lady, the use of methods other than drugs such as taking a shower, massages in the lower back region and breathing exercises as well as liberty of movement (in cases where this did not go against medical advice).",100.0
712,The researcher that was responsible for applying the acupressure went through 32 hours' worth of training.,fulltext,The researcher that was responsible for applying the acupressure went through 32 hours' worth of training.,100.0
712,"The SP6 group with the pregnant women in labor received deep pressure (± 5kg) with fast decompression applied to their thumbs which did not bring about any discomfort. The TG group received a superficial touch that was of very low intensity (± 100g) 15 . In both groups the contact was at the SP6 bilateral point, during the contractions, in one period of 20 minutes.",fulltext,"The SP6 group with the pregnant women in labor received deep pressure (± 5kg) with fast decompression applied to their thumbs which did not bring about any discomfort. The TG group received a superficial touch that was of very low intensity (± 100g) 15 . In both groups the contact was at the SP6 bilateral point, during the contractions, in one period of 20 minutes.",100.0
712,A child-cushioned electronic anthropometric scale was used to control and to put consistent pressure on the thumps until the researcher could apply such pressure for the SP6 and TG groups.,fulltext,A child-cushioned electronic anthropometric scale was used to control and to put consistent pressure on the thumps until the researcher could apply such pressure for the SP6 and TG groups.,100.0
712,VAS was used to evaluate the pain and for pre-developed questions. The women were able to classify their perception of the pain (Table 3).,fulltext,VAS was used to evaluate the pain and for pre-developed questions. The women were able to classify their perception of the pain (Table 3).,100.0
712,"For conducting evaluations on the pain we opted for the VAS model which is a rising scale from 0 10, 0 meaning no pain to 10 which is the worst pain felt. The patients registered their pain using a picture of a grimacing face and writing down a number next to it. The VAS was used and reused immediately after the treatment (VAS20) and 60 minutes after the treatment, once consent had been given by the pregnant women in labor to participate in the study.",fulltext,"For conducting evaluations on the pain we opted for the VAS model which is a rising scale from 0 10, 0 meaning no pain to 10 which is the worst pain felt. The patients registered their pain using a picture of a grimacing face and writing down a number next to it. The VAS was used and reused immediately after the treatment (VAS20) and 60 minutes after the treatment, once consent had been given by the pregnant women in labor to participate in the study.",100.0
712,Through an evaluation of the pain we saw a significant reduction in the group that received acupressure in the SP6 point in comparison with the TG and CG groups.,fulltext,Through an evaluation of the pain we saw a significant reduction in the group that received acupressure in the SP6 point in comparison with the TG and CG groups.,100.0
712,"The analgesia epidural or the spinal anesthesia were available for women depending on their need. Their use was as follows: 69.23% in the SP6 group (n 36) and 79.92% (n 40) in the other groups (Chi-squared test, p=0.5840).",fulltext,"The analgesia epidural or the spinal anesthesia were available for women depending on their need. Their use was as follows: 69.23% in the SP6 group (n 36) and 79.92% (n 40) in the other groups (Chi-squared test, p=0.5840).",100.0
713,Inclusion criteria were patients aged 45-65 with mild and moderate COPD (grade II and III) as the primary disease.,fulltext,Inclusion criteria were patients aged 45-65 with mild and moderate COPD (grade II and III) as the primary disease.,100.0
713,"Excluded were individuals who had another major disease (among them individuals with asthma who had more than 200 ml or 12% increase in FEV1 after inhalation of 200 μg albuterol in the post-bronchodilator spirometry), who were non-Icelandic speaking, not capable of travelling to the treatment site and those who had participated in a structured rehabilitation programme for people with COPD 6 months prior to the screening.",fulltext,"Excluded were individuals who had another major disease (among them individuals with asthma who had more than 200 ml or 12% increase in FEV1 after inhalation of 200 μg albuterol in the post-bronchodilator spirometry), who were non-Icelandic speaking, not capable of travelling to the treatment site and those who had participated in a structured rehabilitation programme for people with COPD 6 months prior to the screening.",100.0
713,"An invitation letter signed by the patient's physician was sent to potential participants explaining that the study was a clinical, family trial and that as a client of the physician, the person had been identified as a possible participant and that in addition, participation by a close family member was requested.",fulltext,"An invitation letter signed by the patient's physician was sent to potential participants explaining that the study was a clinical, family trial and that as a client of the physician, the person had been identified as a possible participant and that in addition, participation by a close family member was requested.",100.0
713,"One to two weeks later the patient was contacted by phone. In the phone call, possibilities for participation were explored. An appointment at the research centre was set up for those who accepted the invitation.",fulltext,"One to two weeks later the patient was contacted by phone. In the phone call, possibilities for participation were explored. An appointment at the research centre was set up for those who accepted the invitation.",100.0
713,The treatment site was a clinical research centre located on a university-hospital campus.,fulltext,The treatment site was a clinical research centre located on a university-hospital campus.,100.0
713,Attendance at treatment sessions in the experimental group was more than 80% in the patient/family conversations (43/48 attended three or four out of the four possible meetings) and the group meeting (40/48).,fulltext,Attendance at treatment sessions in the experimental group was more than 80% in the patient/family conversations (43/48 attended three or four out of the four possible meetings) and the group meeting (40/48).,100.0
713,The number and length of conversations varied depending on identified needs.,fulltext,) Number and length of conversations varied depending on identified needs,94.73684210526316
713,"Being ready to quit, having a belief in one's capacity to quit, and having a strong motivation to quit were of central importance (Miller & Rollnick 2002). The change from being a smoker to becoming a non-smoker was considered a process and participants given time to progress through that process as needed (DiClemente et al. 1991).",fulltext," Being ready to quit, having a belief in one's capacity to quit, and having a strong motivation to quit were of central importance (Miller & Rollnick 2002). The change from being a smoker to becoming a non-smoker was considered a process and participants given time to progress through that process as needed (DiClemente et al. 1991)",99.69969969969969
713,"Data were collected at baseline and at month 12. Additionally, data collection was carried out in the experimental group at month 6 after the last treatment session.",fulltext,"Data were collected at baseline and at month 12. Additionally, data collection was carried out in the experimental group at month 6 after the last treatment session.",100.0
714,From their computerised asthma registers the practices identified adults (⩾18 years) who had asked for a bronchodilator inhaler prescription in the previous six months but who had not had a routine asthma review in the preceding 11 months.,fulltext,From their computerised asthma registers the practices identified adults (⩾18 years) who had asked for a bronchodilator inhaler prescription in the previous six months but who had not had a routine asthma review in the preceding 11 months.,100.0
714,"Patients were excluded if the diagnosis of asthma had been made within the previous year, if they had chronic obstructive pulmonary disease, if communication difficulties made a telephone consultation impossible, or (at the general practitioner's request) for major social or medical reasons.",fulltext,"Patients were excluded if the diagnosis of asthma had been made within the previous year, if they had chronic obstructive pulmonary disease, if communication difficulties made a telephone consultation impossible, or (at the general practitioner's request) for major social or medical reasons.",100.0
714,We wrote to all eligible patients inviting them to take part in the study.,fulltext,We wrote to all eligible patients inviting them to take part in the study.,100.0
714,Patients were free to arrange any consultations they wished.,fulltext,Patients were free to arrange any consultations they wished.,100.0
714,All four general practices that took part in the study had nurses who were trained and experienced in providing proactive asthma care.,fulltext,All four general practices that took part in the study had nurses who were trained and experienced in providing proactive asthma care.,100.0
714,Using validated instruments we obtained data on several clinical and practice related outcomes.,fulltext,Using validated instruments we obtained data on several clinical and practice related outcomes.,100.0
714,Nurses were given no instructions about the content of the review except that it should reflect their normal practice and be appropriate to each patient's clinical need.,fulltext,Nurses were given no instructions about the content of the review except that it should reflect their normal practice and be appropriate to each patient's clinical need.,100.0
714,Clinical care and follow up were the same as for the intervention group but without a telephone option.,fulltext,Clinical care and follow up were the same as for the intervention group but without a telephone option.,100.0
714,Patients were free to arrange any consultations they wished.,fulltext,Patients were free to arrange any consultations they wished.,100.0
714,Follow up questionnaires on morbidity and satisfaction with the consultation were sent to the patients at three months.,fulltext,Follow up questionnaires on morbidity and satisfaction with the consultation were sent to the patients at three months.,100.0
714,Our study was of short duration and so we can't comment on the long term impact of telephone assessments.,fulltext,Our study was of short duration and so we can't comment on the long term impact of telephone assessments.,100.0
714,"Primary outcome measures were the proportion of participants who were reviewed within three months of randomisation and disease specific quality of life, as measured by the Juniper mini asthma quality of life questionnaire.",fulltext,"Primary outcome measures were the proportion of participants who were reviewed within three months of randomisation and disease specific quality of life, as measured by the Juniper mini asthma quality of life questionnaire.",100.0
714,"On an intention to treat analysis, 101 of the 137 patients (74%) allocated to the telephone arm were reviewed, compared with 68 of the 141 patients (48%) in the face to face consultation arm (risk difference 26% (95% confidence interval 14% to 37%; P<0.001; number needed to treat 3.8 (2.7 to 7.1)).",fulltext,"On an intention to treat analysis, 101 of the 137 patients (74%) allocated to the telephone arm were reviewed, compared with 68 of the 141 patients (48%) in the face to face consultation arm (risk difference 26% (95% confidence interval 14% to 37%; P<0.001; number needed to treat 3.8 (2.7 to 7.1)).",100.0
715,"The inclusion criteria were: a positive diagnosis of RA (1987 American College of Rheumatology (ACR) criteria),29 age 18 years or older and the ability to complete questionnaires unaided. Exclusions were: unstabilised concomitant disease, awaiting surgery and already receiving care from the practitioners involved in the study.",fulltext,"The inclusion criteria were: a positive diagnosis of RA (1987 American College of Rheumatology (ACR) criteria),29 age 18 years or older and the ability to complete questionnaires unaided. Exclusions were: unstabilised concomitant disease, awaiting surgery and already receiving care from the practitioners involved in the study.",100.0
715,"After gaining patient consent, demographics and disease activity score in 28 joints (DAS28), patients were randomly assigned using a remote secure telephone randomisation service provided by Leeds University Clinical Trials Research Unit.",fulltext,"After gaining patient consent, demographics and disease activity score in 28 joints (DAS28), patients were randomly assigned using a remote secure telephone randomisation service provided by Leeds University Clinical Trials Research Unit.",100.0
715,"When patients arrived at the clinic, the independent assessor performed ‘joint counts’ for DAS28 and then oversaw the completion of self-reported pain visual analogue scale (pain-VAS), fatigue-VAS and duration of morning stiffness.",fulltext,"When patients arrived at the clinic, the independent assessor performed ‘joint counts’ for DAS28 and then oversaw the completion of self-reported pain visual analogue scale (pain-VAS), fatigue-VAS and duration of morning stiffness.",100.0
715,This study was conducted in outpatient clinics of 10 rheumatology centres across the UK.,fulltext,The study was conducted in outpatient clinics of 10 rheumatology centres across the UK.,97.72727272727273
715,"The NLC interventions usually include allocated 30-min time slots in which the CNS takes history, performs physical examination, pain control, prescribing or recommending medication and dosage changes, intra-articular or intramuscular steroid injections, provision of patient education, psychosocial support and ordering blood tests or X-rays. Referrals for ward admission, to the rheumatologist or other health professionals, were carried out as appropriate.",fulltext,"The NLC interventions usually include allocated 30-min time slots in which the CNS takes history, performs physical examination, pain control, prescribing or recommending medication and dosage changes, intra-articular or intramuscular steroid injections, provision of patient education, psychosocial support and ordering blood tests or X-rays. Referrals for ward admission, to the rheumatologist or other health professionals, were carried out as appropriate.",100.0
715,The usual RLC is similar to the above except that it usually involves an allocated 15-min time slot.,fulltext,The usual RLC is similar to the above except that it usually involves an allocated 15-min time slot.,100.0
715,"Patients were seen by their respective practitioners at baseline and at weeks 13, 26, 39 and 52.",fulltext,"Patients were seen by their respective practitioners at baseline and at weeks 13, 26, 39 and 52.",100.0
715,"The primary outcome was disease activity score in 28 joints (DAS28) and secondary outcomes were pain severity (pain-VAS), fatigue (fatigue-VAS) and duration of morning stiffness measured at each study visit.",fulltext,"The primary outcome was DAS28 and secondary outcomes were pain severity (pain-VAS), fatigue (fatigue-VAS) and duration of morning stiffness measured at each study visit.",81.64251207729468
715,Analysis followed per-protocol (PP) and intention-to-treat (ITT) approaches.,fulltext,Analysis followed per-protocol (PP) and intention-to-treat (ITT) approaches.,100.0
722,"Men and women aged ≥18 years at high CVD risk, defined as either established CVD (history of coronary, ischaemic cerebrovascular, or peripheral vascular disease) or an estimated five-year CVD risk of ≥15% (using the Framingham risk equation, including a 5% increment for Aboriginal or Torres Strait Islander identification)21 were eligible. Each participant had to have, in their doctor’s view, indications for all and no contraindications to any component of at least one of two polypills – version 1 (containing aspirin 75 mg, simvastatin 40 mg, lisinopril 10 mg, atenolol 50 mg) or version 2 (containing aspirin 75 mg, simvastatin 40 mg, lisinopril 10 mg, hydrochlorothiazide 12.5 mg).",fulltext,"Men and women aged ≥18 years at high CVD risk, defined as either established CVD (history of coronary, ischaemic cerebrovascular, or peripheral vascular disease) or an estimated five-year CVD risk of ≥15% (using the Framingham risk equation, including a 5% increment for Aboriginal or Torres Strait Islander identification)21 were eligible. Each participant had to have, in their doctor’s view, indications for all and no contraindications to any component of at least one of two polypills – version 1 (containing aspirin 75 mg, simvastatin 40 mg, lisinopril 10 mg, atenolol 50 mg) or version 2 (containing aspirin 75 mg, simvastatin 40 mg, lisinopril 10 mg, hydrochlorothiazide 12.5 mg).",100.0
722,All participants were treated by their regular doctor following randomization.,fulltext,All participants were treated by their regular doctor following randomization.,100.0
722,"All patient care was provided through existing primary healthcare practices, with rural and remote communities included to ensure that ‘real-life’ variations in healthcare delivery were captured.",fulltext,"All patient care was provided through existing primary healthcare practices, with rural and remote communities included to ensure that ‘real-life’ variations in healthcare delivery were captured.",100.0
722,"Prescription and dispensing of the polypill occurred in the same way as for other medications. This mostly involved doctors providing patients with written prescriptions, and patients presenting the prescriptions to designated local pharmacies where all drugs (including the polypill) were dispensed.",fulltext,"Prescription and dispensing of the polypill occurred in the same way as for other medications. This mostly involved doctors providing patients with written prescriptions, and patients presenting the prescriptions to designated local pharmacies where all drugs (including the polypill) were dispensed.",100.0
722,"Those allocated to the polypill-based strategy were prescribed one of the polypill versions at the discretion of their doctor, to be taken at a time suggested by the doctor. No attempt was made to influence any other aspect of their management. The doctor could, at any time, change prescription to the alternative polypill version, add drugs on top of the polypill, or withdraw the polypill and substitute individual drugs of their choice.",fulltext,"Those allocated to the polypill-based strategy were prescribed one of the polypill versions at the discretion of their doctor, to be taken at a time suggested by the doctor. No attempt was made to influence any other aspect of their management. The doctor could, at any time, change prescription to the alternative polypill version, add drugs on top of the polypill, or withdraw the polypill and substitute individual drugs of their choice.",100.0
722,"Those allocated to the polypill-based strategy were prescribed one of the polypill versions at the discretion of their doctor, to be taken at a time suggested by the doctor.",fulltext,"Those allocated to the polypill-based strategy were prescribed one of the polypill versions at the discretion of their doctor, to be taken at a time suggested by the doctor.",100.0
722,"Participants attended the primary healthcare centres for trial assessments at randomization and 12 month intervals thereafter. All participants were also reviewed one month post-randomization and at intervening six month intervals, but these could be conducted by telephone.",fulltext,"Participants attended the primary healthcare centres for trial assessments at randomization and 12 month intervals thereafter. All participants were also reviewed one month post-randomization and at intervening six month intervals, but these could be conducted by telephone.",100.0
722,"Primary outcomes were self-reported use of indicated combination treatment (antiplatelet, statin and ≥2 blood pressure lowering therapies for ≥4 of the previous seven days) at study end; and changes in systolic BP and total cholesterol from baseline to study end.",fulltext,"Primary outcomes were self-reported use of indicated combination treatment (antiplatelet, statin and ≥2 BP lowering therapies for ≥4 of the previous seven days) at study end; and changes in systolic BP and total cholesterol from baseline to study end.",95.43726235741445
722,All analyses were conducted on an intention-to-treat basis without imputation of missing data.,fulltext,All analyses were conducted on an intention-to-treat basis without imputation of missing data.,100.0
725,Patients were eligible for inclusion if they were aged 16 years or older and presented within 3 weeks after sustaining a displaced fracture of the proximal humerus that involved the surgical neck.,fulltext,Patients were eligible for inclusion if they were aged 16 years or older and presented within 3 weeks after sustaining a displaced fracture of the proximal humerus that involved the surgical neck.,100.0
725,"Excluded patients had associated dislocation of the injured shoulder joint, open fracture, insufficient mental capacity to understand the trial or instructions for rehabilitation, comorbidities precluding surgery or anesthesia, clear indication for surgery such as severe soft-tissue compromise, multiple injuries (upper limb fractures), pathological fracture (other than osteoporotic), terminal illness, or were not a resident in the hospital catchment area.",fulltext,"Excluded patients had associated dislocation of the injured shoulder joint, open fracture, insufficient mental capacity to understand the trial or instructions for rehabilitation, comorbidities precluding surgery or anesthesia, clear indication for surgery such as severe soft-tissue compromise, multiple injuries (upper limb fractures), pathological fracture (other than osteoporotic), terminal illness, or were not a resident in the hospital catchment area.",100.0
725,Patients received their allocated treatment from the recruiting hospital.,fulltext,Patients received their allocated treatment from the recruiting hospital.,100.0
725,"Reflecting known differences in osteoporosis-related fracture risk among different races, trial participants were asked to identify whether they were white, black, Asian, or other.",fulltext,"Reflecting known differences in osteoporosis-related fracture risk among different races, trial participants were asked to identify whether they were white, black, Asian, or other.",100.0
725,There was 1 additional National Health Service hospital that screened but failed to recruit patients into the PROFHER trial. All 33 hospitals routinely provide surgical and nonsurgical fracture treatment.,fulltext,There was 1 additional National Health Service hospital that screened but failed to recruit patients into the PROFHER trial. All 33 hospitals routinely provide surgical and nonsurgical fracture treatment.,100.0
725,"Physiotherapy treatment log data demonstrated equal access and implementation between groups, with similarly high numbers of participants recorded as performing home exercises (109 in surgical group vs 103 in nonsurgical group) in both groups.",fulltext,"Physiotherapy treatment log data demonstrated equal access and implementation between groups, with similarly high numbers of participants recorded as performing home exercises (109 in surgical group vs 103 in nonsurgical group) in both groups.",100.0
725,"It was emphasized that good standards of care, both surgical and nonsurgical, should be provided throughout the treatment pathway for the injury, including surgical care or management of the sling, postoperative care, and rehabilitation in both groups.",fulltext,"It was emphasized that good standards of care, both surgical and nonsurgical, should be provided throughout the treatment pathway for the injury, including surgical care or management of the sling, postoperative care, and rehabilitation in both groups.",100.0
725,"Consistent with the study protocol, 29 of 32 recruiting centers (91%) recommended 3 or more weeks of sling use.",fulltext,"Consistent with the study protocol, 29 of 32 recruiting centers (91%) recommended 3 or more weeks of sling use.",100.0
725,"To avoid learning curve problems, surgeons and physiotherapists used surgical interventions and procedures with which they were familiar.",fulltext,"To avoid learning curve problems, surgeons and physiotherapists used surgical interventions and procedures with which they were familiar.",100.0
725,"Consistent with the study protocol, 29 of 32 recruiting centers (91%) recommended 3 or more weeks of sling use.",fulltext,"Consistent with the study protocol, 29 of 32 recruiting centers (91%) recommended 3 or more weeks of sling use.",100.0
725,Follow-up was up to 2 years (until April 2013) for all patients.,fulltext,Follow-up was up to 2 years (until April 2013) for all patients.,100.0
725,There was no trial-related clinical assessment or radiological follow-up of patients.,fulltext,There was no trial-related clinical assessment or radiological follow-up of patients.,100.0
725,"The primary outcome was the Oxford Shoulder Score (OSS), which is a shoulder-specific outcome measure validated in a UK population. The OSS provides a total score based on the patient’s subjective assessment of pain and function.",fulltext,"The primary outcome was the Oxford Shoulder Score (OSS), which is a shoulder-specific outcome measure validated in a UK population.12 The OSS provides a total score based on the patient’s subjective assessment of pain and function.",100.0
725,All analyses were on an intention-to-treat basis and included all randomized patients in the groups to which they were randomized.,fulltext,All analyses were on an intention-to-treat basis and included all randomized patients in the groups to which they were randomized.,100.0
733,Patients were eligible to participate if they were: community dwelling aged ≥65 years; independently mobile (with or without a walking aid); and physically able to take part in group exercise. Patients were excluded if they: had experienced ≥3 falls in the previous year; had unstable clinical conditions; would be unable to follow instructions about exercise safely; or were receiving palliative care.,fulltext,Patients were eligible to participate if they were: community dwelling aged ≥65 years; independently mobile (with or without a walking aid); and physically able to take part in group exercise. Patients were excluded if they: had experienced ≥3 falls in the previous year; had unstable clinical conditions; would be unable to follow instructions about exercise safely; or were receiving palliative care.,100.0
733,"Practices were recruited with assistance from Primary Care Research Networks for London, Derby, and Nottingham. Patients aged ≥65 years were identified by searches of computerised medical records and invited to participate by letter from their GP.",fulltext,"Practices were recruited with assistance from Primary Care Research Networks for London, Derby, and Nottingham. Patients aged ≥65 years were identified by searches of computerised medical records and invited to participate by letter from their GP.",100.0
733,"The FaME intervention took place in a group once a week and included exercises to be carried out at home, unsupervised, twice weekly. The OEP was undertaken at home, unsupervised, and comprised exercises to be done three times per week.",fulltext,"The FaME intervention took place in a group once a week and included exercises to be carried out at home, unsupervised, twice weekly. The OEP was undertaken at home, unsupervised, and comprised exercises to be done three times per week.",100.0
733,Weekly FaME classes were run in local venues by postural stability instructors trained to work with older people. Both interventions were delivered for 24 weeks.,fulltext,Weekly FaME classes were run in local venues by postural stability instructors trained to work with older people. Both interventions were delivered for 24 weeks.,100.0
733,"The programmes included the following progression: OEP — ankle weights and hand holds; and FaME — resistance bands and hand holds, plus a move to more dynamic balance work and floor work with postural stability instructors.",fulltext,"The programmes included the following progression: OEP — ankle weights and hand holds; and FaME — resistance bands and hand holds, plus a move to more dynamic balance work and floor work with postural stability instructors.",100.0
733,"Adherence was defined as (minutes spent exercising/intended minutes) 100%, where patients with values exceeding 75% were regarded as ‘adherent’.",fulltext,"Adherence was defined as (minutes spent exercising/intended minutes) 100%, where patients with values exceeding 75% were regarded as ‘adherent’.",100.0
733,"Participants were followed up every 6 months after the end of the intervention period, until 24 months. The primary time point was chosen as 12 months post-intervention to match other trials.",fulltext,"Participants were followed up every 6 months after the end of the intervention period, until 24 months. The primary time point was chosen as 12 months post-intervention to match other trials.",100.0
733,The primary outcome was the proportion of participants who reported reaching ≥150 minutes of MVPA per week. Physical activity was assessed using three validated questionnaires.,fulltext,The primary outcome was the proportion of participants who reported reaching ≥150 minutes of MVPA per week. Physical activity was assessed using three validated questionnaires.,100.0
733,"Participants were analysed in the groups to which they were randomised, regardless of whether they received the intervention or not, and multiple imputation was used to include all participants in the analyses.",fulltext,"Participants were analysed in the groups to which they were randomised, regardless of whether they received the intervention or not, and multiple imputation was used to include all participants in the analyses.",100.0
